| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | deubiquitinase activity | USP17L21 USP17L20 USP9X USP17L19 USP9Y MYSM1 USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.90e-15 | 124 | 239 | 18 | GO:0101005 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | CYBRD1 SLC22A11 SLC12A8 ABCB1 ABCB4 SLC2A10 CLCN3 CLCN5 CLCN7 SLC22A10 SLC11A2 SLC16A9 ABCB6 ABCC9 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC6A4 SLC9A5 SLC11A1 SLC16A5 ABCA6 SLC22A2 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 XPR1 | 1.77e-14 | 477 | 239 | 31 | GO:0022804 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.18e-14 | 114 | 239 | 17 | GO:0004843 |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | USP17L21 USP17L20 USP9X USP17L19 USP9Y MYSM1 USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.31e-14 | 137 | 239 | 18 | GO:0019783 |
| GeneOntologyMolecularFunction | cysteine-type peptidase activity | USP17L21 USP17L20 USP9X CTSC USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.82e-11 | 192 | 239 | 18 | GO:0008234 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CYBRD1 BEST2 SPNS2 SLC22A11 SLC12A8 ABCB1 ABCB4 SLC2A10 CLCN3 CLCN5 CLCN7 SLC22A10 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 SLC16A9 ABCB6 ABCC9 CALHM6 TTYH3 SLC7A7 CALHM2 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC6A4 SLC9A5 SLC11A1 SLC16A6 SLC16A5 ABCA6 SLC22A2 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 XPR1 | 5.15e-11 | 1180 | 239 | 43 | GO:0022857 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC22A11 SLC12A8 SLC2A10 CLCN3 CLCN5 CLCN7 SLC22A10 SLC11A2 SLC16A9 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC6A4 SLC9A5 SLC11A1 SLC16A5 SLC28A2 SLC26A11 SLC6A14 XPR1 | 7.37e-11 | 296 | 239 | 21 | GO:0015291 |
| GeneOntologyMolecularFunction | transporter activity | CYBRD1 BEST2 SPNS2 SLC22A11 SLC12A8 ABCB1 ABCB4 SLC2A10 CLCN3 CLCN5 CLCN7 SLC22A10 TMEM38A KCNMA1 CACNA1G GLTPD2 CACNA1F CACNA1S SLC11A2 SLC16A9 ABCB6 ABCC9 CALHM6 TTYH3 SLC7A7 CALHM2 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC6A4 SLC9A5 SLC11A1 SLC16A6 SLC16A5 ABCA6 SLC22A2 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 XPR1 | 2.41e-10 | 1289 | 239 | 44 | GO:0005215 |
| GeneOntologyMolecularFunction | peptidase activity | USP17L21 SPG7 USP17L20 ADAM21 USP9X CTSC USP17L19 USP9Y MYSM1 USP17L18 USP17L17 USP32 MMP7 USP17L13 RHBDF1 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 XPNPEP2 APH1A TLL1 USP17L6P USP17L22 USP17L15 | 9.06e-08 | 654 | 239 | 26 | GO:0008233 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | BEST2 SLC22A11 SLC12A8 SLC2A10 CLCN3 CLCN5 CLCN7 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 TTYH3 SLC4A1 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 XPR1 | 1.29e-07 | 758 | 239 | 28 | GO:0015318 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | BEST2 SLC12A8 SLC2A10 CLCN3 CLCN5 CLCN7 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 CALHM6 TTYH3 CALHM2 SLC4A1 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 | 3.23e-07 | 793 | 239 | 28 | GO:0015075 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A8 SLC2A10 SLC11A2 ABCC9 SLC4A1 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 | 7.57e-07 | 301 | 239 | 16 | GO:0022853 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | BEST2 SLC22A11 SLC12A8 CLCN3 CLCN5 CLCN7 ABCC9 TTYH3 SLC4A1 SLC6A4 SLC26A11 XPR1 | 1.08e-06 | 171 | 239 | 12 | GO:0015103 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.78e-06 | 18 | 239 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | antiporter activity | SLC22A11 CLCN3 CLCN5 CLCN7 SLC4A1 SLC7A9 SLC6A4 SLC9A5 SLC11A1 SLC26A11 | 6.48e-06 | 138 | 239 | 10 | GO:0015297 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | BEST2 SLC22A11 ABCB1 SLC2A10 SLC22A10 SLC16A9 SLC7A7 SLC4A1 SLC7A9 SLC16A6 SLC16A5 SLC22A2 SLC26A11 SLC6A14 | 1.27e-05 | 293 | 239 | 14 | GO:0008514 |
| GeneOntologyMolecularFunction | symporter activity | SLC12A8 SLC2A10 SLC11A2 SLC16A9 SLC5A2 SLC5A3 SLC6A4 SLC16A5 SLC28A2 SLC6A14 | 1.35e-05 | 150 | 239 | 10 | GO:0015293 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A8 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC28A2 ATP1A2 ATP1B2 ATP2A2 SLC6A14 | 1.36e-05 | 465 | 239 | 18 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | BEST2 SLC12A8 SLC2A10 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 CALHM6 CALHM2 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC28A2 ATP1A2 ATP1B2 ATP2A2 SLC6A14 | 1.72e-05 | 664 | 239 | 22 | GO:0008324 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.85e-05 | 28 | 239 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | BEST2 SLC12A8 CLCN3 CLCN5 CLCN7 TTYH3 SLC4A1 SLC6A4 SLC26A11 | 1.99e-05 | 125 | 239 | 9 | GO:0015108 |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 3.25e-05 | 16 | 239 | 4 | GO:0015562 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.03e-05 | 109 | 239 | 8 | GO:0042626 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | SPG7 MYO1C MYO7A ATAD5 DNAH14 ABCB1 ABCB4 DDX10 DNAH5 DYNC1H1 DNAH3 DYNC2H1 ABCB6 ABCC9 CHD1L ABCA6 HELZ2 ATP1A2 ATP1B2 ATP2A2 | 5.32e-05 | 614 | 239 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 7.51e-05 | 37 | 239 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | sphingolipid transporter activity | 8.34e-05 | 20 | 239 | 4 | GO:0046624 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | BEST2 SLC12A8 CLCN3 CLCN5 CLCN7 TTYH3 SLC4A1 SLC6A4 SLC26A11 | 8.77e-05 | 151 | 239 | 9 | GO:0008509 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | SPG7 ATAD5 ABCB1 ABCB4 DDX10 DNAH5 DYNC1H1 DNAH3 DYNC2H1 ABCB6 ABCC9 CHD1L ABCA6 HELZ2 ATP1A2 ATP2A2 | 8.84e-05 | 441 | 239 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC12A8 SLC2A10 SLC11A2 SLC5A2 SLC5A3 SLC6A4 SLC28A2 SLC6A14 | 9.38e-05 | 119 | 239 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC12A8 SLC2A10 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC28A2 ATP1A2 ATP1B2 ATP2A2 SLC6A14 | 2.08e-04 | 627 | 239 | 19 | GO:0022890 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | CACNA1G SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC28A2 ATP1A2 ATP1B2 SLC6A14 | 2.25e-04 | 171 | 239 | 9 | GO:0015081 |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 2.60e-04 | 11 | 239 | 3 | GO:0005247 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 2.92e-04 | 49 | 239 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 3.03e-04 | 178 | 239 | 9 | GO:0015399 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR2AK2 ADGRV1 OPN1SW GPR179 ADRA1B GPR158 GLP1R MRGPRG P2RY14 OR4D5 ADGRL3 CYSLTR2 NPY5R GPR33 FFAR2 MRGPRE TAAR5 OR14A16 OR51F1 MTNR1B OR56A5 OR56A4 OR56A1 | 4.12e-04 | 884 | 239 | 23 | GO:0004930 |
| GeneOntologyMolecularFunction | cadmium ion transmembrane transporter activity | 4.25e-04 | 3 | 239 | 2 | GO:0015086 | |
| GeneOntologyMolecularFunction | RNA uridylyltransferase activity | 4.25e-04 | 3 | 239 | 2 | GO:0050265 | |
| GeneOntologyMolecularFunction | ceramide floppase activity | 4.25e-04 | 3 | 239 | 2 | GO:0099038 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | BEST2 CLCN3 CLCN5 CLCN7 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S ABCC9 CALHM6 TTYH3 CALHM2 SLC6A4 SLC26A11 | 4.47e-04 | 459 | 239 | 15 | GO:0005216 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.51e-04 | 118 | 239 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 5.59e-04 | 14 | 239 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | chloride channel activity | 5.84e-04 | 86 | 239 | 6 | GO:0005254 | |
| GeneOntologyMolecularFunction | quaternary ammonium group transmembrane transporter activity | 6.93e-04 | 15 | 239 | 3 | GO:0015651 | |
| GeneOntologyMolecularFunction | volume-sensitive chloride channel activity | 8.43e-04 | 4 | 239 | 2 | GO:0072320 | |
| GeneOntologyMolecularFunction | sphingolipid floppase activity | 8.43e-04 | 4 | 239 | 2 | GO:0046623 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | ABCB1 SLC22A10 SLC16A9 SLC7A7 SLC7A9 SLC16A6 SLC16A5 SLC22A2 SLC6A14 | 9.01e-04 | 207 | 239 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | ABCB1 SLC22A10 SLC16A9 SLC7A7 SLC7A9 SLC16A6 SLC16A5 SLC22A2 SLC6A14 | 9.32e-04 | 208 | 239 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | carbohydrate:monoatomic cation symporter activity | 1.02e-03 | 17 | 239 | 3 | GO:0005402 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.02e-03 | 17 | 239 | 3 | GO:0008308 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | SPG7 ATAD5 ABCB1 ABCB4 DDX10 RAB40B DNAH5 DYNC1H1 AGAP2 DNAH3 DYNC2H1 ABCB6 ABCC9 CHD1L ARL10 ABCA6 HELZ2 RAB40C ATP1A2 ATP2A2 | 1.09e-03 | 775 | 239 | 20 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | SPG7 ATAD5 ABCB1 ABCB4 DDX10 RAB40B DNAH5 DYNC1H1 AGAP2 DNAH3 DYNC2H1 ABCB6 ABCC9 NUDT22 CHD1L ARL10 ABCA6 HELZ2 RAB40C ATP1A2 ATP2A2 | 1.20e-03 | 839 | 239 | 21 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | SPG7 ATAD5 ABCB1 ABCB4 DDX10 RAB40B DNAH5 DYNC1H1 AGAP2 DNAH3 DYNC2H1 ABCB6 ABCC9 NUDT22 CHD1L ARL10 ABCA6 HELZ2 RAB40C ATP1A2 ATP2A2 | 1.22e-03 | 840 | 239 | 21 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | SPG7 ATAD5 ABCB1 ABCB4 DDX10 RAB40B DNAH5 DYNC1H1 AGAP2 DNAH3 DYNC2H1 ABCB6 ABCC9 NUDT22 CHD1L ARL10 ABCA6 HELZ2 RAB40C ATP1A2 ATP2A2 | 1.22e-03 | 840 | 239 | 21 | GO:0016818 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | 1.50e-03 | 103 | 239 | 6 | GO:0005253 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.51e-03 | 70 | 239 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 1.61e-03 | 182 | 239 | 8 | GO:0005244 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 1.66e-03 | 20 | 239 | 3 | GO:0015174 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 1.72e-03 | 184 | 239 | 8 | GO:0022832 | |
| GeneOntologyMolecularFunction | channel activity | BEST2 CLCN3 CLCN5 CLCN7 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S ABCC9 CALHM6 TTYH3 CALHM2 SLC6A4 SLC26A11 | 1.72e-03 | 525 | 239 | 15 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | BEST2 CLCN3 CLCN5 CLCN7 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S ABCC9 CALHM6 TTYH3 CALHM2 SLC6A4 SLC26A11 | 1.76e-03 | 526 | 239 | 15 | GO:0022803 |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 1.92e-03 | 21 | 239 | 3 | GO:0005326 | |
| GeneOntologyMolecularFunction | carnitine transmembrane transporter activity | 2.07e-03 | 6 | 239 | 2 | GO:0015226 | |
| GeneOntologyMolecularFunction | gated channel activity | BEST2 CLCN3 CLCN5 CLCN7 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S ABCC9 TTYH3 | 2.40e-03 | 334 | 239 | 11 | GO:0022836 |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.55e-03 | 196 | 239 | 8 | GO:0005319 | |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 2.88e-03 | 7 | 239 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | uridylyltransferase activity | 2.88e-03 | 7 | 239 | 2 | GO:0070569 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 2.88e-03 | 81 | 239 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | hexose transmembrane transporter activity | 3.21e-03 | 25 | 239 | 3 | GO:0015149 | |
| GeneOntologyMolecularFunction | D-glucose transmembrane transporter activity | 3.21e-03 | 25 | 239 | 3 | GO:0055056 | |
| GeneOntologyMolecularFunction | pyrimidine nucleoside transmembrane transporter activity | 3.81e-03 | 8 | 239 | 2 | GO:0015214 | |
| GeneOntologyMolecularFunction | phosphatidylcholine floppase activity | 3.81e-03 | 8 | 239 | 2 | GO:0090554 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 4.01e-03 | 27 | 239 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 4.05e-03 | 167 | 239 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | volume-sensitive anion channel activity | 4.86e-03 | 9 | 239 | 2 | GO:0005225 | |
| GeneOntologyMolecularFunction | amine transmembrane transporter activity | 4.86e-03 | 9 | 239 | 2 | GO:0005275 | |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 4.92e-03 | 29 | 239 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 4.92e-03 | 29 | 239 | 3 | GO:0051119 | |
| GeneOntologyBiologicalProcess | protein deubiquitination | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 7.93e-14 | 125 | 237 | 17 | GO:0016579 |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.48e-13 | 144 | 237 | 17 | GO:0070646 |
| GeneOntologyBiologicalProcess | organic anion transport | CES1 BEST2 SLC22A11 ABCB1 ABCB4 SLC2A10 SLC22A10 GLTPD2 NPY5R SLC16A9 TTYH3 SLC7A7 CALHM2 SLC4A1 SLC7A9 PLA2R1 LLGL2 SLC11A1 SLC16A6 SLC16A5 SLC22A2 ATP1A2 SLC26A11 SLC6A14 | 6.96e-09 | 515 | 237 | 24 | GO:0015711 |
| GeneOntologyBiologicalProcess | inorganic anion transport | BEST2 SLC22A11 SLC12A8 ABCB1 CLCN3 CLCN5 CLCN7 TTYH3 SLC4A1 SLC11A1 ROS1 SLC26A11 SLC6A14 XPR1 | 2.26e-08 | 180 | 237 | 14 | GO:0015698 |
| GeneOntologyBiologicalProcess | import across plasma membrane | SLC12A8 SLC2A10 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 SLC5A2 SLC5A3 SLC9A5 SLC22A2 ATP1A2 ATP1B2 SLC6A14 | 4.72e-07 | 230 | 237 | 14 | GO:0098739 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CYBRD1 SPG7 BEST2 SLC22A11 SLC12A8 ABCB1 SLC2A10 CLCN3 CLCN5 CLCN7 GLP1R SLC22A10 TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCB6 ABCC9 SPG11 CALHM6 TTYH3 CALHM2 SLC4A1 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC22A2 DHRS7C ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 | 1.11e-06 | 1374 | 237 | 37 | GO:0006811 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CES1 SLC22A11 ABCB1 ABCB4 NPY5R SLC16A9 TTYH3 SLC7A7 SLC7A9 PLA2R1 LLGL2 SLC11A1 SLC16A6 SLC16A5 SLC22A2 ATP1A2 SLC26A11 SLC6A14 | 1.36e-06 | 410 | 237 | 18 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CES1 SLC22A11 ABCB1 ABCB4 NPY5R SLC16A9 TTYH3 SLC7A7 SLC7A9 PLA2R1 LLGL2 SLC11A1 SLC16A6 SLC16A5 SLC22A2 ATP1A2 SLC26A11 SLC6A14 | 1.46e-06 | 412 | 237 | 18 | GO:0015849 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SPG7 BEST2 SLC12A8 ABCB1 SLC2A10 CLCN3 CLCN5 CLCN7 GLP1R TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCB6 ABCC9 CALHM6 TTYH3 CALHM2 SLC4A1 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 | 1.72e-06 | 1115 | 237 | 32 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SPG7 BEST2 SLC12A8 SLC2A10 CLCN3 CLCN5 CLCN7 GLP1R TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCB6 ABCC9 TTYH3 SLC4A1 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 XPR1 | 2.16e-06 | 1017 | 237 | 30 | GO:0098660 |
| GeneOntologyBiologicalProcess | chloride transport | BEST2 SLC12A8 ABCB1 CLCN3 CLCN5 CLCN7 TTYH3 SLC4A1 SLC26A11 SLC6A14 | 2.30e-06 | 128 | 237 | 10 | GO:0006821 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | SLC12A8 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 SLC5A2 SLC9A5 ATP1A2 ATP1B2 | 5.86e-06 | 142 | 237 | 10 | GO:0098659 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | SLC12A8 CACNA1G CACNA1F CACNA1S SLC11A2 ABCC9 SLC5A2 SLC9A5 ATP1A2 ATP1B2 | 5.86e-06 | 142 | 237 | 10 | GO:0099587 |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 7.22e-06 | 87 | 237 | 8 | GO:0150104 | |
| GeneOntologyBiologicalProcess | vascular transport | 7.87e-06 | 88 | 237 | 8 | GO:0010232 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | BEST2 SLC12A8 ABCB1 CLCN3 CLCN5 CLCN7 ABCC9 TTYH3 SLC4A1 SLC26A11 SLC6A14 | 9.18e-06 | 183 | 237 | 11 | GO:0006820 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | BEST2 SLC12A8 ABCB1 CLCN3 CLCN5 CLCN7 ABCC9 TTYH3 SLC4A1 SLC26A11 | 1.13e-05 | 153 | 237 | 10 | GO:0098656 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 2.52e-05 | 134 | 237 | 9 | GO:0098661 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | SPG7 BEST2 SLC12A8 SLC2A10 CLCN3 GLP1R TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCB6 ABCC9 CALHM6 CALHM2 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 ATP2A2 SLC6A14 | 3.38e-05 | 942 | 237 | 26 | GO:0098655 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 4.60e-05 | 112 | 237 | 8 | GO:1902476 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | ABCB1 SLC2A10 ADRA1B KCNMA1 CACNA1G PLOD3 ABCC9 SLC5A3 SLC6A4 SLC22A2 MTNR1B SLC28A2 ATP1A2 ATP1B2 | 4.77e-05 | 344 | 237 | 14 | GO:0003018 |
| GeneOntologyBiologicalProcess | basic amino acid transmembrane transport | 5.75e-05 | 19 | 237 | 4 | GO:1990822 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CYBRD1 SPG7 BEST2 SLC12A8 SLC2A10 CLCN3 GLP1R TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCB6 ABCC9 SPG11 CALHM6 CALHM2 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 SLC22A2 DHRS7C ATP1A2 ATP1B2 ATP2A2 SLC6A14 | 6.67e-05 | 1157 | 237 | 29 | GO:0006812 |
| GeneOntologyBiologicalProcess | protein deubiquitination involved in ubiquitin-dependent protein catabolic process | 8.04e-05 | 8 | 237 | 3 | GO:0071947 | |
| GeneOntologyBiologicalProcess | amino acid transport | NPY5R TTYH3 SLC7A7 SLC7A9 SLC6A4 LLGL2 SLC11A1 SLC22A2 ATP1A2 SLC6A14 | 9.01e-05 | 195 | 237 | 10 | GO:0006865 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MYO1C SPTA1 SLC12A8 ADRA1B CLCN3 KCNMA1 CACNA1G PLOD3 DSCAM NTRK3 RTN4 RDX ABCC9 ALS2 MSN SLC6A4 MEGF8 MTNR1B ATP1A2 | 1.03e-04 | 618 | 237 | 19 | GO:0090066 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | USP17L21 USP17L20 USP9X MARCHF6 USP17L19 EIPR1 USP9Y TRIP12 USP17L18 FBXO25 USP17L17 USP32 RAB40B USP17L13 USP17L12 USP17L11 USP17L24 SOCS3 USP17L5 USP17L10 MEGF8 NEURL1 USP17L6P RAB40C USP17L22 USP17L15 | 1.05e-04 | 1009 | 237 | 26 | GO:0070647 |
| GeneOntologyBiologicalProcess | basic amino acid transport | 1.06e-04 | 22 | 237 | 4 | GO:0015802 | |
| GeneOntologyBiologicalProcess | import into cell | MYO1C MYO7A SLC12A8 SIRPB2 SLC2A10 CLCN3 CLCN5 CACNA1G HEATR5B CACNA1F CACNA1S SLC11A2 SYNE1 ABCC9 SPG11 SLC5A2 SLC5A3 SLC6A4 PLA2R1 SLC9A5 SLC11A1 CSK SLC22A2 ATP1A2 LY75 ATP1B2 SLC6A14 | 1.15e-04 | 1074 | 237 | 27 | GO:0098657 |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | ABCB1 SLC16A9 TTYH3 SLC7A7 SLC7A9 SLC11A1 SLC16A6 SLC22A2 ATP1A2 | 1.39e-04 | 167 | 237 | 9 | GO:1903825 |
| GeneOntologyBiologicalProcess | regulation of protein localization to early endosome | 1.69e-04 | 10 | 237 | 3 | GO:1902965 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to early endosome | 1.69e-04 | 10 | 237 | 3 | GO:1902966 | |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species biosynthetic process | 2.08e-04 | 26 | 237 | 4 | GO:1903428 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | HEXB CYBRD1 CES1 SLC12A8 ABCB4 ADRA1B CLCN3 GLP1R TMEM38A KCNMA1 PKHD1 FOXO3 CACNA1F CACNA1S SLC11A2 FFAR2 RTN4 ABCB6 PNPLA5 SLC4A1 SLC9A5 SLC11A1 DHRS7C MTNR1B ATP1A2 ATP1B2 ATP2A2 ACOXL XPR1 | 2.47e-04 | 1249 | 237 | 29 | GO:0048878 |
| GeneOntologyBiologicalProcess | L-amino acid transport | 2.52e-04 | 108 | 237 | 7 | GO:0015807 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | HEXB CYBRD1 CLCN3 GLP1R TMEM38A KCNMA1 PKHD1 CACNA1F CACNA1S SLC11A2 ABCB6 SLC4A1 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 ATP2A2 | 2.63e-04 | 611 | 237 | 18 | GO:0030003 |
| GeneOntologyBiologicalProcess | post-translational protein modification | USP17L21 USP17L20 USP9X MARCHF6 USP17L19 EIPR1 USP9Y TRIP12 USP17L18 FBXO25 USP17L17 USP32 RAB40B USP17L13 USP17L12 USP17L11 USP17L24 SOCS3 USP17L5 USP17L10 MEGF8 NEURL1 USP17L6P RAB40C USP17L22 USP17L15 | 2.79e-04 | 1074 | 237 | 26 | GO:0043687 |
| GeneOntologyBiologicalProcess | action potential propagation | 3.05e-04 | 12 | 237 | 3 | GO:0098870 | |
| GeneOntologyBiologicalProcess | neuronal action potential propagation | 3.05e-04 | 12 | 237 | 3 | GO:0019227 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | HEXB CYBRD1 CLCN3 GLP1R TMEM38A KCNMA1 PKHD1 CACNA1F CACNA1S SLC11A2 ABCB6 SLC4A1 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 ATP2A2 | 3.26e-04 | 622 | 237 | 18 | GO:0006873 |
| GeneOntologyBiologicalProcess | cellular detoxification of cadmium ion | 3.91e-04 | 3 | 237 | 2 | GO:0098849 | |
| GeneOntologyBiologicalProcess | establishment of endothelial blood-brain barrier | 3.91e-04 | 3 | 237 | 2 | GO:0014045 | |
| GeneOntologyBiologicalProcess | polyuridylation-dependent mRNA catabolic process | 3.91e-04 | 3 | 237 | 2 | GO:1990074 | |
| GeneOntologyBiologicalProcess | ceramide translocation | 3.91e-04 | 3 | 237 | 2 | GO:0099040 | |
| GeneOntologyBiologicalProcess | cellular detoxification of metal ion | 3.91e-04 | 3 | 237 | 2 | GO:0140961 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SPG7 SLC12A8 SLC2A10 CLCN3 GLP1R TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCB6 ABCC9 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 ATP2A2 SLC6A14 | 4.20e-04 | 922 | 237 | 23 | GO:0098662 |
| GeneOntologyBiologicalProcess | locomotory behavior | HEXB IDO1 ADRA1B CLCN3 KCNMA1 ULK4 ADGRL3 DSCAM ALS2 SPG11 ATP1A2 | 4.69e-04 | 284 | 237 | 11 | GO:0007626 |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 4.79e-04 | 120 | 237 | 7 | GO:0003333 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to endosome | 4.97e-04 | 14 | 237 | 3 | GO:1905668 | |
| GeneOntologyBiologicalProcess | branched-chain amino acid transport | 4.97e-04 | 14 | 237 | 3 | GO:0015803 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 5.02e-04 | 87 | 237 | 6 | GO:1902475 | |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | HEXB CYBRD1 SLC12A8 CLCN3 GLP1R TMEM38A KCNMA1 PKHD1 CACNA1F CACNA1S SLC11A2 ABCB6 SLC4A1 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 ATP2A2 | 5.36e-04 | 705 | 237 | 19 | GO:0055080 |
| GeneOntologyBiologicalProcess | metal ion transport | CYBRD1 SPG7 SLC12A8 GLP1R TMEM38A KCNMA1 CACNA1G CACNA1F CACNA1S SLC11A2 ABCB6 ABCC9 SPG11 CALHM2 SLC5A2 SLC5A3 SLC6A4 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 ATP2A2 SLC6A14 | 5.46e-04 | 1000 | 237 | 24 | GO:0030001 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 6.09e-04 | 163 | 237 | 8 | GO:1905039 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to endosome | 6.15e-04 | 15 | 237 | 3 | GO:1905666 | |
| GeneOntologyBiologicalProcess | L-arginine transmembrane transport | 6.15e-04 | 15 | 237 | 3 | GO:1903826 | |
| GeneOntologyBiologicalProcess | fatty acid elongation | 6.15e-04 | 15 | 237 | 3 | GO:0030497 | |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | HEXB CYBRD1 SLC12A8 CLCN3 GLP1R TMEM38A KCNMA1 PKHD1 CACNA1F CACNA1S SLC11A2 ABCB6 SLC4A1 SLC9A5 SLC11A1 DHRS7C ATP1A2 ATP1B2 ATP2A2 | 6.57e-04 | 717 | 237 | 19 | GO:0050801 |
| GeneOntologyBiologicalProcess | microtubule-based transport | 7.23e-04 | 253 | 237 | 10 | GO:0099111 | |
| GeneOntologyBiologicalProcess | protein localization to early endosome | 7.51e-04 | 16 | 237 | 3 | GO:1902946 | |
| GeneOntologyBiologicalProcess | regulation of transepithelial transport | 7.77e-04 | 4 | 237 | 2 | GO:0150111 | |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 8.33e-04 | 37 | 237 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | retina homeostasis | 8.43e-04 | 64 | 237 | 5 | GO:0001895 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | USP17L21 DPY19L3 CYP3A5 USP17L20 CYP19A1 MARCHF6 HLA-F USP17L19 DDOST MYORG NSDHL USP17L18 DST USP17L17 TMEM38A ALG12 USP17L13 PLOD3 RHBDF1 USP17L12 USP17L11 SYNE1 TECR RTN4 USP17L5 ABCB6 USP17L10 HACD2 SACM1L TRAM1L1 APH1A DHRS7C USP17L6P HSD17B12 USP17L22 ATP2A2 USP17L15 | 4.33e-07 | 1327 | 239 | 37 | GO:0042175 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | USP17L21 DPY19L3 CYP3A5 USP17L20 CYP19A1 MARCHF6 HLA-F USP17L19 DDOST MYORG NSDHL USP17L18 DST USP17L17 TMEM38A ALG12 USP17L13 PLOD3 RHBDF1 USP17L12 USP17L11 TECR RTN4 USP17L5 ABCB6 USP17L10 HACD2 SACM1L TRAM1L1 APH1A DHRS7C USP17L6P HSD17B12 USP17L22 ATP2A2 USP17L15 | 6.56e-07 | 1293 | 239 | 36 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | USP17L21 DPY19L3 CYP3A5 USP17L20 CYP19A1 MARCHF6 HLA-F USP17L19 DDOST MYORG NSDHL USP17L18 DST USP17L17 TMEM38A ALG12 USP17L13 PLOD3 RHBDF1 USP17L12 USP17L11 TECR RTN4 USP17L5 ABCB6 USP17L10 HACD2 SACM1L TRAM1L1 APH1A DHRS7C USP17L6P HSD17B12 USP17L22 ATP2A2 USP17L15 | 7.31e-07 | 1299 | 239 | 36 | GO:0098827 |
| GeneOntologyCellularComponent | apical part of cell | CYBRD1 MYO7A USP9X SLC22A11 ABCB1 ABCB4 CLCN3 CLCN5 KCNMA1 PKHD1 SLC11A2 DYNC2H1 RDX SLC5A2 SLC5A3 MSN SLC7A9 SLC22A2 ATP1B2 SLC26A11 SLC6A14 | 4.89e-06 | 592 | 239 | 21 | GO:0045177 |
| GeneOntologyCellularComponent | basal part of cell | MYO1C BEST2 SLC22A11 DST SLC22A10 SLC11A2 SLC7A7 SLC4A1 SLC5A3 MSN LLGL1 SLC16A6 SLC16A5 SLC22A2 CLDN19 SLC26A11 | 7.96e-06 | 378 | 239 | 16 | GO:0045178 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | CYBRD1 MYO1C IDO1 MYO7A ADGRV1 RSPH9 SLC11A2 RDX SLC5A2 SLC7A9 SLC28A2 SLC6A14 | 1.06e-05 | 223 | 239 | 12 | GO:0098862 |
| GeneOntologyCellularComponent | apical plasma membrane | CYBRD1 MYO7A SLC22A11 ABCB1 ABCB4 CLCN3 KCNMA1 PKHD1 SLC11A2 RDX SLC5A2 SLC5A3 MSN SLC7A9 SLC22A2 ATP1B2 SLC26A11 SLC6A14 | 1.38e-05 | 487 | 239 | 18 | GO:0016324 |
| GeneOntologyCellularComponent | basal plasma membrane | MYO1C BEST2 SLC22A11 DST SLC22A10 SLC7A7 SLC4A1 SLC5A3 MSN LLGL1 SLC16A6 SLC16A5 SLC22A2 CLDN19 SLC26A11 | 1.52e-05 | 354 | 239 | 15 | GO:0009925 |
| GeneOntologyCellularComponent | longitudinal sarcoplasmic reticulum | 1.30e-04 | 2 | 239 | 2 | GO:0014801 | |
| GeneOntologyCellularComponent | T-tubule | 2.91e-04 | 79 | 239 | 6 | GO:0030315 | |
| GeneOntologyCellularComponent | stereocilium bundle | 2.91e-04 | 79 | 239 | 6 | GO:0032421 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | BEST2 SLC22A10 SLC7A7 SLC4A1 SLC5A3 MSN LLGL1 SLC16A6 SLC16A5 SLC22A2 CLDN19 SLC26A11 | 3.35e-04 | 320 | 239 | 12 | GO:0016323 |
| GeneOntologyCellularComponent | dynein complex | 3.75e-04 | 54 | 239 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | brush border membrane | 3.80e-04 | 83 | 239 | 6 | GO:0031526 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 4.09e-04 | 55 | 239 | 5 | GO:0098533 | |
| GeneOntologyCellularComponent | lysosome | HEXB GALC CYBRD1 MYO7A CTSC HLA-F ANKRD27 DDOST CLCN3 CLCN5 CLCN7 ACAN DYNC1H1 TECPR1 SLC11A2 ABCB6 SPG11 SLC11A1 ARSD ASAH1 SLC26A11 | 4.36e-04 | 811 | 239 | 21 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | HEXB GALC CYBRD1 MYO7A CTSC HLA-F ANKRD27 DDOST CLCN3 CLCN5 CLCN7 ACAN DYNC1H1 TECPR1 SLC11A2 ABCB6 SPG11 SLC11A1 ARSD ASAH1 SLC26A11 | 4.36e-04 | 811 | 239 | 21 | GO:0000323 |
| GeneOntologyCellularComponent | vacuole | HEXB GALC CYBRD1 MYO7A CTSC HLA-F ANKRD27 DDOST CLCN3 CLCN5 CLCN7 ACAN DYNC1H1 TECPR1 SLC11A2 ABCB6 SPG11 TBC1D17 SLC11A1 ARSD ASAH1 SLC26A11 | 8.32e-04 | 913 | 239 | 22 | GO:0005773 |
| GeneOntologyCellularComponent | cell tip | 8.91e-04 | 17 | 239 | 3 | GO:0051286 | |
| GeneOntologyCellularComponent | intercalated disc | 1.09e-03 | 68 | 239 | 5 | GO:0014704 | |
| GeneOntologyCellularComponent | side of membrane | ADAM21 SPTA1 SLC22A11 HLA-F ABCB1 DST CLCN3 CD163L1 KCNMA1 PKHD1 ALCAM ALG12 AGAP2 NOA1 SOCS3 XPNPEP2 SLC4A1 MSN LY75 ATP1B2 ATP2A2 | 1.15e-03 | 875 | 239 | 21 | GO:0098552 |
| GeneOntologyCellularComponent | cell projection membrane | CYBRD1 MYO1C ADGRV1 CLCN3 SLC11A2 FSCN3 SLC5A2 MSN SLC7A9 SLC9A5 SLC28A2 ATP1B2 SLC6A14 | 1.45e-03 | 431 | 239 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | cell pole | 1.46e-03 | 20 | 239 | 3 | GO:0060187 | |
| GeneOntologyCellularComponent | sarcolemma | 1.59e-03 | 190 | 239 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | brush border | 1.86e-03 | 152 | 239 | 7 | GO:0005903 | |
| GeneOntologyCellularComponent | stereocilium membrane | 1.89e-03 | 6 | 239 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 2.36e-03 | 49 | 239 | 4 | GO:0090533 | |
| GeneOntologyCellularComponent | lysosomal membrane | CYBRD1 MYO7A HLA-F DDOST CLCN3 CLCN5 CLCN7 TECPR1 SLC11A2 ABCB6 SPG11 SLC11A1 SLC26A11 | 2.67e-03 | 462 | 239 | 13 | GO:0005765 |
| GeneOntologyCellularComponent | lytic vacuole membrane | CYBRD1 MYO7A HLA-F DDOST CLCN3 CLCN5 CLCN7 TECPR1 SLC11A2 ABCB6 SPG11 SLC11A1 SLC26A11 | 2.67e-03 | 462 | 239 | 13 | GO:0098852 |
| GeneOntologyCellularComponent | transmembrane transporter complex | BEST2 CLCN7 KCNMA1 CACNA1G CACNA1F CACNA1S ABCB6 ABCC9 TTYH3 SACM1L SLC5A3 ATP1A2 ATP1B2 ATP2A2 | 2.91e-03 | 523 | 239 | 14 | GO:1902495 |
| GeneOntologyCellularComponent | axon | SPG7 ADAM21 USP9X CYP19A1 SPTA1 OPN1SW DST CLCN3 KCNMA1 ALCAM DYNC1H1 ADGRL3 MAP2K4 DSCAM FSCN3 NTRK3 ALS2 SPG11 LLGL1 TANC1 | 3.24e-03 | 891 | 239 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | cell-cell junction | ABCB1 ABCB4 ADRA1B DST ADGRL3 RDX CLDN3 SLC4A1 MSN LLGL2 LLGL1 CSK CLDN19 ATP1A2 ATP2A2 | 3.44e-03 | 591 | 239 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | stereocilia coupling link | 3.48e-03 | 8 | 239 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | stereocilium base | 3.48e-03 | 8 | 239 | 2 | GO:0120044 | |
| MousePheno | neurodegeneration | HEXB GALC SPG7 MYO7A ADGRV1 ABCB1 DST CLCN3 CLCN7 KCNMA1 CACNA1G DYNC1H1 CACNA1F NTRK3 RDX ALS2 SPG11 MSI1 NEMF ATP1B2 | 3.06e-06 | 468 | 182 | 20 | MP:0002229 |
| MousePheno | neuron degeneration | HEXB MYO7A ADGRV1 ABCB1 DST CLCN3 CLCN7 KCNMA1 CACNA1G DYNC1H1 CACNA1F NTRK3 RDX SPG11 MSI1 NEMF ATP1B2 | 1.41e-05 | 391 | 182 | 17 | MP:0003224 |
| MousePheno | weight loss | HEXB GALC CTSC ABCB1 ABCB4 DST MMP7 RHBDF1 SPG11 HACD2 SLC7A7 SLC4A1 ASAH1 LTB ATP2A2 | 1.43e-05 | 312 | 182 | 15 | MP:0001263 |
| MousePheno | abnormal locomotor coordination | HEXB GALC SPG7 MYO7A CYP19A1 MYSM1 DST CLCN3 ACAN KCNMA1 CACNA1G DNAH5 DYNC1H1 RHBDF1 DSCAM GPR33 NTRK3 SPG11 MSI1 ASAH1 NEMF NEURL1 CLDN19 SLC26A11 | 2.43e-05 | 726 | 182 | 24 | MP:0003312 |
| MousePheno | abnormal gait | HEXB GALC MYO7A CYP19A1 MYSM1 DST CLCN3 ACAN KCNMA1 CACNA1G DNAH5 DYNC1H1 DSCAM GPR33 SPG11 ASAH1 NEMF CLDN19 SLC26A11 | 4.86e-05 | 520 | 182 | 19 | MP:0001406 |
| MousePheno | astrocytosis | 5.87e-05 | 103 | 182 | 8 | MP:0003354 | |
| MousePheno | decreased mean corpuscular hemoglobin concentration | 7.14e-05 | 136 | 182 | 9 | MP:0005642 | |
| MousePheno | increased astrocyte number | 7.70e-05 | 107 | 182 | 8 | MP:0012065 | |
| MousePheno | gliosis | 8.08e-05 | 171 | 182 | 10 | MP:0002183 | |
| MousePheno | hydrocephaly | FREM2 ULK4 DNAH5 RSPH9 MPV17L2 DSCAM MTF2 MSI1 SLC7A7 LLGL1 ASAH1 | 9.21e-05 | 209 | 182 | 11 | MP:0001891 |
| MousePheno | abnormal astrocyte number | 1.06e-04 | 112 | 182 | 8 | MP:0012064 | |
| MousePheno | abnormal mean corpuscular hemoglobin concentration | MYO1C CYP19A1 SPTA1 MYSM1 ABCB4 USP32 RAB40B SLC11A2 TTYH3 SLC9A5 ABCA6 SLC6A14 | 1.19e-04 | 253 | 182 | 12 | MP:0005640 |
| MousePheno | atrial septal defect | 1.48e-04 | 88 | 182 | 7 | MP:0010403 | |
| MousePheno | absent cochlear hair bundle ankle links | 1.69e-04 | 2 | 182 | 2 | MP:0004582 | |
| MousePheno | abnormal cochlear hair bundle ankle links morphology | 1.69e-04 | 2 | 182 | 2 | MP:0004581 | |
| MousePheno | microcytosis | 1.69e-04 | 22 | 182 | 4 | MP:0002813 | |
| MousePheno | abnormal cochlear sensory neuron innervation pattern | 1.69e-04 | 22 | 182 | 4 | MP:0014489 | |
| MousePheno | impaired coordination | HEXB GALC SPG7 DST CLCN3 KCNMA1 CACNA1G DYNC1H1 RHBDF1 DSCAM SYNE1 NTRK3 ALS2 SPG11 CLDN19 ATP1A2 ATP1B2 | 1.70e-04 | 478 | 182 | 17 | MP:0001405 |
| MousePheno | tremors | HEXB GALC CYP19A1 MYSM1 ABCB1 DST CLCN3 CLCN7 KCNMA1 CACNA1G ALG12 DYNC1H1 SLC7A7 ATP1B2 | 2.16e-04 | 353 | 182 | 14 | MP:0000745 |
| MousePheno | peripheral nervous system degeneration | 2.44e-04 | 10 | 182 | 3 | MP:0000958 | |
| MousePheno | increased circulating aspartate transaminase level | HEXB CES1 CYP19A1 MARCHF6 ABCB4 MEI4 PAPOLA P2RY14 FFAR2 RDX ABCA6 ASAH1 TANC1 | 2.48e-04 | 315 | 182 | 13 | MP:0005343 |
| MousePheno | abnormal postnatal growth | GALC MYO7A DST CLCN3 CLCN7 KCNMA1 PKHD1 ULK4 DNAH5 RSPH9 DYNC1H1 TUT4 SLC11A2 RHBDF1 DSCAM MTF2 SYNE1 ABCC9 HACD2 SLC7A7 SLC4A1 ASAH1 NEMF HELZ2 EIF2AK4 | 2.97e-04 | 907 | 182 | 25 | MP:0001731 |
| MousePheno | abnormal cochlear IHC afferent innervation pattern | 3.32e-04 | 11 | 182 | 3 | MP:0004746 | |
| MousePheno | abnormal arginine level | 3.32e-04 | 11 | 182 | 3 | MP:0030663 | |
| MousePheno | slow postnatal weight gain | GALC MYO7A DST DYNC1H1 RHBDF1 ABCC9 SLC7A7 SLC4A1 NEMF HELZ2 | 3.54e-04 | 205 | 182 | 10 | MP:0008489 |
| MousePheno | abnormal thoracic aorta morphology | 3.66e-04 | 134 | 182 | 8 | MP:0010468 | |
| MousePheno | abnormal retina photoreceptor morphology | MYO7A OPN1SW CLCN3 CLCN7 ALCAM CACNA1F OAT MSI1 ATP1B2 BBS12 | 3.68e-04 | 206 | 182 | 10 | MP:0001004 |
| MousePheno | abnormal axonal transport | 3.86e-04 | 27 | 182 | 4 | MP:0004768 | |
| Domain | HABP4_PAI-RBP1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 3.90e-18 | 16 | 234 | 11 | PF04774 |
| Domain | HABP4_PAIRBP1-bd | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L22 | 3.90e-18 | 16 | 234 | 11 | IPR006861 |
| Domain | USP_CS | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 2.86e-15 | 66 | 234 | 15 | IPR018200 |
| Domain | USP_1 | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 7.34e-15 | 70 | 234 | 15 | PS00972 |
| Domain | UCH | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 9.21e-15 | 71 | 234 | 15 | PF00443 |
| Domain | USP_2 | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 9.21e-15 | 71 | 234 | 15 | PS00973 |
| Domain | USP_3 | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 1.15e-14 | 72 | 234 | 15 | PS50235 |
| Domain | USP_dom | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 1.15e-14 | 72 | 234 | 15 | IPR028889 |
| Domain | Peptidase_C19_UCH | USP17L21 USP17L20 USP9X USP17L19 USP9Y USP17L18 USP17L17 USP32 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 | 1.15e-14 | 72 | 234 | 15 | IPR001394 |
| Domain | AAA | SPG7 ATAD5 ABCB1 ABCB4 DNAH5 DYNC1H1 DNAH3 DYNC2H1 ABCB6 ABCC9 ABCA6 HELZ2 | 2.72e-07 | 144 | 234 | 12 | SM00382 |
| Domain | AAA+_ATPase | SPG7 ATAD5 ABCB1 ABCB4 DNAH5 DYNC1H1 DNAH3 DYNC2H1 ABCB6 ABCC9 ABCA6 HELZ2 | 2.72e-07 | 144 | 234 | 12 | IPR003593 |
| Domain | Dynein_heavy_chain_D4_dom | 5.40e-07 | 14 | 234 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.40e-07 | 14 | 234 | 5 | IPR024743 | |
| Domain | MT | 5.40e-07 | 14 | 234 | 5 | PF12777 | |
| Domain | AAA_8 | 5.40e-07 | 14 | 234 | 5 | PF12780 | |
| Domain | DHC_fam | 8.02e-07 | 15 | 234 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 8.02e-07 | 15 | 234 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 8.02e-07 | 15 | 234 | 5 | IPR004273 | |
| Domain | NTP_transf_2 | 7.40e-06 | 11 | 234 | 4 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 7.40e-06 | 11 | 234 | 4 | IPR002934 | |
| Domain | Dynein_heavy_dom-2 | 2.18e-05 | 14 | 234 | 4 | IPR013602 | |
| Domain | DHC_N2 | 2.18e-05 | 14 | 234 | 4 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 2.18e-05 | 14 | 234 | 4 | IPR011704 | |
| Domain | AAA_5 | 2.18e-05 | 14 | 234 | 4 | PF07728 | |
| Domain | MFS_dom | SPNS2 SLC22A11 UNC93A SLC2A10 SLC22A10 SLC16A9 SLC16A6 SLC16A5 SLC22A2 | 4.90e-05 | 134 | 234 | 9 | IPR020846 |
| Domain | MFS | SPNS2 SLC22A11 SLC2A10 SLC22A10 SLC16A9 SLC16A6 SLC16A5 SLC22A2 | 6.46e-05 | 108 | 234 | 8 | PS50850 |
| Domain | DHC_N1 | 1.04e-04 | 8 | 234 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 1.04e-04 | 8 | 234 | 3 | IPR013594 | |
| Domain | Cl-channel_core | 1.54e-04 | 9 | 234 | 3 | IPR014743 | |
| Domain | - | 1.54e-04 | 9 | 234 | 3 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 1.54e-04 | 9 | 234 | 3 | PF00654 | |
| Domain | Cl-channel_volt-gated | 1.54e-04 | 9 | 234 | 3 | IPR001807 | |
| Domain | Nramp | 1.56e-04 | 2 | 234 | 2 | PF01566 | |
| Domain | NRAMP_fam | 1.56e-04 | 2 | 234 | 2 | IPR001046 | |
| Domain | ABC_membrane | 2.10e-04 | 24 | 234 | 4 | PF00664 | |
| Domain | VDCCAlpha1 | 2.18e-04 | 10 | 234 | 3 | IPR002077 | |
| Domain | ABC_tran | 3.26e-04 | 48 | 234 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 3.26e-04 | 48 | 234 | 5 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 3.60e-04 | 49 | 234 | 5 | PS00211 | |
| Domain | ABC_TM1F | 3.88e-04 | 28 | 234 | 4 | PS50929 | |
| Domain | ABC1_TM_dom | 3.88e-04 | 28 | 234 | 4 | IPR011527 | |
| Domain | ABC_transporter-like | 3.96e-04 | 50 | 234 | 5 | IPR003439 | |
| Domain | MFS_1 | 4.10e-04 | 77 | 234 | 6 | PF07690 | |
| Domain | MFS | 4.10e-04 | 77 | 234 | 6 | IPR011701 | |
| Domain | P-loop_NTPase | SPG7 MYO1C MYO7A ATAD5 GAL3ST2 DNAH14 ABCB1 ABCB4 DDX10 RAB40B DNAH5 DYNC1H1 AGAP2 DNAH3 DYNC2H1 NOA1 ABCB6 ABCC9 CHD1L ARL10 ABCA6 HELZ2 RAB40C | 4.32e-04 | 848 | 234 | 23 | IPR027417 |
| Domain | - | 4.65e-04 | 3 | 234 | 2 | 3.30.70.590 | |
| Domain | NuclTrfase_I_C | 4.65e-04 | 3 | 234 | 2 | IPR011068 | |
| Domain | PAP_central | 4.65e-04 | 3 | 234 | 2 | PF04928 | |
| Domain | PAP_RNA-bind | 4.65e-04 | 3 | 234 | 2 | PF04926 | |
| Domain | PolA_pol_cen_dom | 4.65e-04 | 3 | 234 | 2 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 4.65e-04 | 3 | 234 | 2 | IPR007010 | |
| Domain | PolyA_polymerase | 4.65e-04 | 3 | 234 | 2 | IPR014492 | |
| Domain | - | SPG7 MYO7A ATAD5 DNAH14 ABCB1 ABCB4 DDX10 RAB40B DNAH5 DYNC1H1 AGAP2 DNAH3 DYNC2H1 NOA1 ABCB6 ABCC9 CHD1L ARL10 ABCA6 HELZ2 RAB40C | 4.77e-04 | 746 | 234 | 21 | 3.40.50.300 |
| Domain | ERM_C_dom | 9.22e-04 | 4 | 234 | 2 | IPR011259 | |
| Domain | LLGL | 9.22e-04 | 4 | 234 | 2 | PF08366 | |
| Domain | G8_domain | 9.22e-04 | 4 | 234 | 2 | IPR019316 | |
| Domain | G8 | 9.22e-04 | 4 | 234 | 2 | PS51484 | |
| Domain | VDCC_L_a1su | 9.22e-04 | 4 | 234 | 2 | IPR005446 | |
| Domain | G8 | 9.22e-04 | 4 | 234 | 2 | SM01225 | |
| Domain | Lethal2_giant | 9.22e-04 | 4 | 234 | 2 | IPR000664 | |
| Domain | G8 | 9.22e-04 | 4 | 234 | 2 | PF10162 | |
| Domain | ERM | 9.22e-04 | 4 | 234 | 2 | PF00769 | |
| Domain | ERM | 9.22e-04 | 4 | 234 | 2 | IPR011174 | |
| Domain | LLGL2 | 9.22e-04 | 4 | 234 | 2 | IPR013577 | |
| Domain | CBS | 9.64e-04 | 16 | 234 | 3 | SM00116 | |
| Domain | MFS_sugar_transport-like | 1.03e-03 | 36 | 234 | 4 | IPR005828 | |
| Domain | Sugar_tr | 1.03e-03 | 36 | 234 | 4 | PF00083 | |
| Domain | ABC_transporter_CS | 1.85e-03 | 42 | 234 | 4 | IPR017871 | |
| Domain | CBS_dom | 1.89e-03 | 20 | 234 | 3 | IPR000644 | |
| Domain | CBS | 1.89e-03 | 20 | 234 | 3 | PF00571 | |
| Domain | CBS | 1.89e-03 | 20 | 234 | 3 | PS51371 | |
| Domain | SOCS | 1.89e-03 | 20 | 234 | 3 | SM00253 | |
| Domain | Ca_hom_mod | 2.27e-03 | 6 | 234 | 2 | PF14798 | |
| Domain | FAM26 | 2.27e-03 | 6 | 234 | 2 | IPR029569 | |
| Domain | AA-permease/SLC12A_dom | 2.51e-03 | 22 | 234 | 3 | IPR004841 | |
| Domain | AA_permease | 2.51e-03 | 22 | 234 | 3 | PF00324 | |
| Domain | Spectrin | 2.86e-03 | 23 | 234 | 3 | PF00435 | |
| Domain | zf-CCHC | 2.86e-03 | 23 | 234 | 3 | PF00098 | |
| Domain | Moesin_tail | 3.15e-03 | 7 | 234 | 2 | IPR008954 | |
| Domain | Ca_chan_IQ | 3.15e-03 | 7 | 234 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 3.15e-03 | 7 | 234 | 2 | PF08763 | |
| Domain | VDCC_a1su_IQ | 3.15e-03 | 7 | 234 | 2 | IPR014873 | |
| Domain | GPHH | 3.15e-03 | 7 | 234 | 2 | PF16905 | |
| Domain | PAP_assoc | 3.15e-03 | 7 | 234 | 2 | PF03828 | |
| Domain | GPHH_dom | 3.15e-03 | 7 | 234 | 2 | IPR031649 | |
| Domain | PAP_assoc | 3.15e-03 | 7 | 234 | 2 | IPR002058 | |
| Pathway | REACTOME_RAS_PROCESSING | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.22e-14 | 45 | 186 | 13 | MM15671 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CYBRD1 SPG7 BEST2 SLC22A11 ABCB1 ABCB4 SLC2A10 CLCN3 PSME4 CLCN5 CLCN7 SLC11A2 ABCB6 ABCC9 TTYH3 SLC7A7 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC9A5 SLC11A1 ABCA6 SLC22A2 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 | 3.15e-08 | 736 | 186 | 30 | M27287 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L20 USP9X USP17L19 USP17L18 PSME4 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.43e-08 | 191 | 186 | 15 | MM15289 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | CYBRD1 SPG7 BEST2 ABCB1 ABCB4 SLC2A10 PSME4 CLCN5 CLCN7 SLC11A2 ABCB6 ABCC9 TTYH3 SLC7A7 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC9A5 SLC11A1 ABCA6 SLC22A2 SLC28A2 ATP1A2 ATP1B2 SLC26A11 ATP2A2 SLC6A14 | 8.05e-08 | 681 | 186 | 28 | MM14985 |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | USP17L21 USP17L20 SPTA1 USP17L19 USP17L18 PSME4 USP17L17 USP17L13 KLB FOXO3 USP17L12 USP17L11 USP17L5 USP17L10 CSK USP17L6P USP17L22 USP17L15 | 2.18e-07 | 318 | 186 | 18 | MM15278 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | USP17L21 USP17L20 USP9X USP17L19 USP17L18 PSME4 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.34e-07 | 221 | 186 | 15 | M27578 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L20 USP9X USP17L19 MYSM1 USP17L18 PSME4 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.86e-07 | 262 | 186 | 16 | MM15286 |
| Pathway | REACTOME_DEUBIQUITINATION | USP17L21 USP17L20 USP9X USP17L19 MYSM1 USP17L18 PSME4 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L22 USP17L15 | 2.22e-06 | 299 | 186 | 16 | M27574 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC22A11 SLC2A10 SLC11A2 SLC7A7 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC9A5 SLC11A1 SLC22A2 SLC28A2 SLC26A11 SLC6A14 | 5.54e-06 | 249 | 186 | 14 | M5988 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A10 SLC11A2 SLC7A7 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC9A5 SLC11A1 SLC22A2 SLC28A2 SLC26A11 SLC6A14 | 1.65e-05 | 238 | 186 | 13 | MM15076 |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | ABCB4 SLC2A10 PSME4 SLC11A2 ABCB6 ABCC9 SLC7A7 SLC4A1 SLC5A2 SLC7A9 SLC6A14 | 2.29e-05 | 177 | 186 | 11 | M27476 |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 1.01e-04 | 57 | 186 | 6 | M39812 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 2.71e-04 | 44 | 186 | 5 | M11911 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 3.33e-04 | 99 | 186 | 7 | M27474 | |
| Pubmed | DUB-1, a deubiquitinating enzyme with growth-suppressing activity. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-23 | 21 | 242 | 13 | 8622927 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-23 | 21 | 242 | 13 | 14583620 | |
| Pubmed | DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-23 | 21 | 242 | 13 | 11468161 |
| Pubmed | The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-23 | 21 | 242 | 13 | 8756639 |
| Pubmed | Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-23 | 21 | 242 | 13 | 12447969 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.25e-23 | 21 | 242 | 13 | 18980247 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.05e-23 | 22 | 242 | 13 | 9154835 | |
| Pubmed | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.51e-22 | 24 | 242 | 13 | 8995226 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.11e-22 | 33 | 242 | 14 | 20228807 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.13e-22 | 25 | 242 | 13 | 21115691 | |
| Pubmed | DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 14699124 |
| Pubmed | The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 15780755 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 17109758 | |
| Pubmed | Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 20715989 |
| Pubmed | Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 9806828 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 20403174 | |
| Pubmed | USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 19188362 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 11941478 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 20388806 | |
| Pubmed | The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 20368735 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 10936051 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.25e-22 | 34 | 242 | 14 | 21448158 | |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 6.21e-22 | 26 | 242 | 13 | 35816173 | |
| Pubmed | Cytokine-regulated protein degradation by the ubiquitination system. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.69e-22 | 35 | 242 | 14 | 16611142 |
| Pubmed | Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.69e-22 | 35 | 242 | 14 | 21239494 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.41e-21 | 36 | 242 | 14 | 20147298 | |
| Pubmed | Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.26e-21 | 37 | 242 | 14 | 20228808 |
| Pubmed | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.98e-21 | 29 | 242 | 13 | 32527007 | |
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.83e-17 | 50 | 242 | 13 | 31806660 |
| Pubmed | USP17L21 USP17L20 HLA-F UNC93A USP17L19 NSDHL USP17L18 CLCN5 USP17L17 NYNRIN USP17L13 USP17L12 USP17L11 NTRK3 USP17L5 USP17L10 XPNPEP2 PLA2R1 USP17L6P ATP1A2 LY75 USP17L22 USP17L15 | 4.70e-10 | 674 | 242 | 23 | 37196079 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CYBRD1 MYO1C CTSC SLC22A11 NARS1 ADGRV1 CEMIP2 ABCB1 TMEM38A PKHD1 ALCAM ALOX12 DYNC1H1 TUT4 PLOD3 DYNC2H1 RDX ABCB6 TTYH3 XPNPEP2 SLC4A1 SLC5A2 MSN MEGF8 CSK ASAH1 SLC22A2 SLC26A11 | 7.10e-10 | 1016 | 242 | 28 | 19056867 |
| Pubmed | ANKRD27 DDOST CEMIP2 FREM2 DST CLCN3 PSME4 NOA1 RTN4 TUT7 RDX TBC1D17 SACM1L MSN LLGL2 LLGL1 TLL1 ARMC5 NEMF HSD17B12 TANC1 EIF2AK4 | 1.33e-09 | 650 | 242 | 22 | 38777146 | |
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | USP17L21 USP17L20 USP17L19 DDOST USP17L18 USP17L17 USP17L12 USP17L11 PCDHA13 PCDHA2 | 1.21e-08 | 119 | 242 | 10 | 28625976 |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CLCN3 CLCN5 CLCN7 KCNMA1 CACNA1G CACNA1F CACNA1S ABCC9 ATP1A2 ATP2A2 | 5.37e-08 | 139 | 242 | 10 | 16985003 |
| Pubmed | ABCB1 SLC2A10 ABCC9 CLDN3 SLC5A3 SLC22A2 SLC28A2 ATP1A2 ATP1B2 | 5.54e-08 | 105 | 242 | 9 | 30280653 | |
| Pubmed | Diversity of Ca2+-activated K+ channel transcripts in inner ear hair cells. | 3.33e-07 | 3 | 242 | 3 | 17097837 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 5.25e-07 | 100 | 242 | 8 | 25807483 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPG7 MYO7A CNTROB MYORG DST PSME4 CLCN7 ULK4 DYNC1H1 FOXO3 PLOD3 RHBDF1 CTC1 SOCS3 SPATA20 CLDN3 TTYH3 TBC1D17 NADSYN1 LLGL2 SLC16A5 MEGF8 HELZ2 TANC1 | 9.77e-07 | 1105 | 242 | 24 | 35748872 |
| Pubmed | CYP3A5 CES1 SLC22A11 DDOST ABCB1 ABCB4 ABCB6 ABCC9 ABCA6 SLC22A2 | 1.13e-06 | 193 | 242 | 10 | 19343046 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYO7A NARS1 UNC93A GAL3ST2 TRIP12 DDOST DNAH14 FREM2 DST ALDH16A1 PKHD1 DYNC1H1 NEMP1 CACNA1F DNAH3 USP17L12 IARS1 SLC5A2 SLC26A11 | 1.17e-06 | 736 | 242 | 19 | 29676528 |
| Pubmed | Chloride and the endosomal-lysosomal pathway: emerging roles of CLC chloride transporters. | 1.32e-06 | 4 | 242 | 3 | 17110406 | |
| Pubmed | Rab40C is a novel Varp-binding protein that promotes proteasomal degradation of Varp in melanocytes. | 1.32e-06 | 4 | 242 | 3 | 25661869 | |
| Pubmed | 2.17e-06 | 14 | 242 | 4 | 9373155 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | DPY19L3 CYBRD1 USP9X CEMIP2 QSOX1 CLCN7 TSPAN14 TMPPE DYNC2H1 YIPF4 RTN4 OAT SPG11 TTYH3 HACD2 UNC50 MSN SLC16A6 APH1A NEMF C15orf61 EGFL7 | 5.90e-06 | 1061 | 242 | 22 | 33845483 |
| Pubmed | 6.55e-06 | 6 | 242 | 3 | 12397396 | ||
| Pubmed | 7.63e-06 | 102 | 242 | 7 | 11214970 | ||
| Pubmed | 1.14e-05 | 7 | 242 | 3 | 16513443 | ||
| Pubmed | 1.14e-05 | 7 | 242 | 3 | 12900400 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | DPY19L3 MARCHF6 ADRA1B CLCN3 CLCN5 TSPAN14 ALCAM ALG12 NEMP1 SYNE1 YIPF4 TTYH3 HACD2 SLC7A7 SACM1L LLGL1 ASAH1 | 1.36e-05 | 719 | 242 | 17 | 35337019 |
| Pubmed | 1.82e-05 | 8 | 242 | 3 | 28330839 | ||
| Pubmed | Chromosomal location of the murine anion exchanger genes encoding AE2 and AE3. | 1.82e-05 | 8 | 242 | 3 | 7894173 | |
| Pubmed | SPNS2 DDOST GPR179 SLC2A10 PSME4 SLC22A10 TMEM38A RSPH9 ADGRL3 CYSLTR2 CTC1 IARS1 NOA1 TUT7 TBL3 TBC1D17 SLC5A2 XPR1 | 2.46e-05 | 832 | 242 | 18 | 36724073 | |
| Pubmed | Changing expression of chloride channels during preimplantation mouse development. | 2.71e-05 | 9 | 242 | 3 | 23115349 | |
| Pubmed | 2.71e-05 | 9 | 242 | 3 | 16382099 | ||
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 2.76e-05 | 84 | 242 | 6 | 15203218 | |
| Pubmed | 3.10e-05 | 225 | 242 | 9 | 12168954 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | USP9X TRIP12 DDOST DDX10 HEATR5B DYNC1H1 NEMP1 DYNC2H1 IARS1 TECR RTN4 TUT7 HACD2 TBL3 SACM1L APH1A HSD17B12 EGFL7 ATP2A2 | 3.77e-05 | 942 | 242 | 19 | 31073040 |
| Pubmed | 3.85e-05 | 10 | 242 | 3 | 12068294 | ||
| Pubmed | Irinotecan pathway genotype analysis to predict pharmacokinetics. | 3.85e-05 | 10 | 242 | 3 | 12960109 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 10488067 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 25590378 | ||
| Pubmed | Multidrug resistance gene expression and ABCB1 SNPs in plasma cell myeloma. | 4.82e-05 | 2 | 242 | 2 | 21705081 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 10552998 | ||
| Pubmed | Genetic dissection of the function of mammalian P-glycoproteins. | 4.82e-05 | 2 | 242 | 2 | 9196326 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 26421491 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 22219375 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 9852958 | ||
| Pubmed | Hugl1 and Hugl2 in mammary epithelial cells: polarity, proliferation, and differentiation. | 4.82e-05 | 2 | 242 | 2 | 23110097 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 8898203 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 38962329 | ||
| Pubmed | Genetic variations in ABCB1 and CYP3A5 as well as sex influence quinine disposition among Ugandans. | 4.82e-05 | 2 | 242 | 2 | 20357698 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 2473069 | ||
| Pubmed | TUT4/7-mediated uridylation of a coronavirus subgenomic RNAs delays viral replication. | 4.82e-05 | 2 | 242 | 2 | 37085578 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 23364483 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 15167702 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 19185004 | ||
| Pubmed | CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. | 4.82e-05 | 2 | 242 | 2 | 15116055 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 15226679 | ||
| Pubmed | Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling. | 4.82e-05 | 2 | 242 | 2 | 20394798 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 26856709 | ||
| Pubmed | Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome. | 4.82e-05 | 2 | 242 | 2 | 12895410 | |
| Pubmed | Genetic analysis of the cytoplasmic dynein subunit families. | 4.82e-05 | 2 | 242 | 2 | 16440056 | |
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 29991328 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 37372371 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 18936931 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 25014506 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 28736028 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 28077574 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 19289993 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 28330783 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 28787093 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 25521359 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 33781609 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 31003147 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 15814280 | ||
| Pubmed | 4.82e-05 | 2 | 242 | 2 | 21839244 | ||
| Pubmed | DNA methylation and FoxO3a regulate PHLPP1 expression in chondrocytes. | 4.82e-05 | 2 | 242 | 2 | 29775231 | |
| Pubmed | Simultaneous detection of CYP3A5 and MDR1 polymorphisms based on the SNaPshot assay. | 4.82e-05 | 2 | 242 | 2 | 21237140 | |
| Pubmed | Multidrug resistance 1 genotype and disposition of budesonide in early primary biliary cirrhosis. | 4.82e-05 | 2 | 242 | 2 | 16584389 | |
| Pubmed | Evolution of differences in transport function in Slc11a family members. | 4.82e-05 | 2 | 242 | 2 | 17932044 | |
| Cytoband | 4p16.1 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 8.51e-18 | 79 | 243 | 14 | 4p16.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4p16 | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 1.87e-11 | 222 | 243 | 14 | chr4p16 |
| Cytoband | 11q21-q22 | 2.76e-04 | 5 | 243 | 2 | 11q21-q22 | |
| Cytoband | 17p13.1 | 4.29e-04 | 118 | 243 | 5 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 5.58e-04 | 346 | 243 | 8 | chr17p13 | |
| Cytoband | 11p15.4 | 7.25e-04 | 200 | 243 | 6 | 11p15.4 | |
| Cytoband | 7q21.1 | 7.65e-04 | 8 | 243 | 2 | 7q21.1 | |
| Cytoband | 17q25.1 | 9.26e-04 | 81 | 243 | 4 | 17q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q25 | 1.33e-03 | 307 | 243 | 7 | chr17q25 | |
| Cytoband | 9q21 | 1.49e-03 | 11 | 243 | 2 | 9q21 | |
| GeneFamily | Solute carriers | SLC22A11 SLC12A8 SLC2A10 SLC22A10 SLC11A2 SLC16A9 SLC7A7 SLC4A1 SLC5A2 SLC5A3 SLC7A9 SLC6A4 SLC9A5 SLC11A1 SLC16A6 SLC16A5 SLC22A2 SLC28A2 SLC26A11 SLC6A14 | 5.82e-10 | 395 | 165 | 20 | 752 |
| GeneFamily | Olfactory receptors, family 56 | 6.02e-05 | 9 | 165 | 3 | 167 | |
| GeneFamily | Chloride voltage-gated channels | 8.54e-05 | 10 | 165 | 3 | 302 | |
| GeneFamily | ATP binding cassette subfamily B | 1.17e-04 | 11 | 165 | 3 | 806 | |
| GeneFamily | Dyneins, axonemal | 4.62e-04 | 17 | 165 | 3 | 536 | |
| GeneFamily | Membrane associated guanylate kinases|PDZ domain containing|Scribble complex | 4.91e-04 | 4 | 165 | 2 | 1224 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 1.48e-03 | 25 | 165 | 3 | 74 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.66e-03 | 26 | 165 | 3 | 253 | |
| GeneFamily | Non-canonical poly(A) polymerases | 1.69e-03 | 7 | 165 | 2 | 1318 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 1.69e-03 | 7 | 165 | 2 | 1208 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 1.69e-03 | 7 | 165 | 2 | 285 | |
| GeneFamily | VPS9 domain containing | 3.55e-03 | 10 | 165 | 2 | 928 | |
| Coexpression | MADAN_DPPA4_TARGETS | USP17L21 USP17L20 USP17L19 ABCB1 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 5.03e-14 | 86 | 240 | 14 | MM1312 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 CLDN3 USP17L6P USP17L22 USP17L15 | 2.16e-12 | 112 | 240 | 14 | MM1095 |
| Coexpression | GERY_CEBP_TARGETS | USP17L21 USP17L20 USP17L19 NSDHL USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.81e-10 | 160 | 240 | 14 | MM1155 |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP | HEXB USP17L21 USP17L20 USP17L19 OPN1SW USP17L18 USP17L17 TMEM38A ALOX12 USP17L13 USP17L12 USP17L11 USP17L5 ALS2 NUDT22 USP17L10 SLC7A7 CALHM2 PLA2R1 USP17L6P RAB40C USP17L22 USP17L15 | 3.49e-08 | 647 | 240 | 23 | MM981 |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP | HEXB USP17L21 USP17L20 USP17L19 OPN1SW STAT2 USP17L18 QSOX1 USP17L17 TMEM38A ALOX12 TECPR1 USP17L13 USP17L12 USP17L11 TUT7 USP17L5 NUDT22 USP17L10 HACD2 SLC7A7 CALHM2 PLA2R1 HELZ2 USP17L6P RAB40C EIF3B USP17L22 USP17L15 | 2.99e-06 | 1226 | 240 | 29 | MM979 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | CYP3A5 MARCHF6 NARS1 DDOST ABCB1 DDX10 DST RAB40B ENOSF1 TECR RTN4 RDX OAT XPNPEP2 SLC7A7 SLC5A3 SLC22A2 ATP2A2 | 3.92e-06 | 553 | 240 | 18 | M1475 |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN | 6.41e-06 | 179 | 240 | 10 | M6689 | |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP | HEXB GALC IDO1 CES1 NARS1 SLC12A8 KCNMA1 PLOD3 SLC11A2 RDX SLC7A7 CALHM2 SLC5A3 SLC16A6 ASAH1 | 6.64e-06 | 411 | 240 | 15 | M19971 |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | USP17L21 USP17L20 CTSC MARCHF6 USP17L19 USP17L18 USP17L17 TBL1X USP17L13 SLC11A2 USP17L12 USP17L11 USP17L5 USP17L10 CHD1L SLC6A4 ARL10 APH1A CSK USP17L6P LTB ATP1A2 USP17L22 BBS12 USP17L15 | 1.91e-05 | 1072 | 240 | 25 | MM1031 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | DPY19L3 HLA-F DDOST SLC2A10 QSOX1 CLCN7 TSPAN14 ALG12 TMPPE PLOD3 SLC11A2 RTN4 HACD2 UNC50 PPP1R10 SLC9A5 HELZ2 HSD17B12 ATP2A2 | 2.87e-05 | 703 | 240 | 19 | MM1055 |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_UP | HEXB IDO1 CES1 NARS1 SLC12A8 KCNMA1 PLOD3 SLC11A2 RDX CALHM2 SLC5A3 SLC16A6 ASAH1 LY75 | 3.76e-05 | 421 | 240 | 14 | M18149 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | DPY19L3 DDOST SLC2A10 QSOX1 CLCN7 TSPAN14 ALG12 TMPPE PLOD3 SLC11A2 RTN4 HACD2 UNC50 PPP1R10 SLC9A5 HELZ2 HSD17B12 ATP2A2 | 6.22e-05 | 681 | 240 | 18 | M5314 |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 8.30e-05 | 195 | 240 | 9 | M7382 | |
| Coexpression | GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN | DPY19L3 ZCCHC2 TSPAN14 TBL1X SLC11A2 IARS1 NOA1 CALHM6 SLC26A11 | 9.69e-05 | 199 | 240 | 9 | M5771 |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP | 1.01e-04 | 200 | 240 | 9 | M4050 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH2_UP | 1.01e-04 | 200 | 240 | 9 | M5534 | |
| ToppCell | Enterocyte|World / shred on cell type and cluster | CYBRD1 CYP3A5 CES1 ABCB1 DST OAT XPNPEP2 SLC7A7 SLC7A9 SLC6A4 SLC28A2 | 9.10e-09 | 197 | 236 | 11 | 1dd980fd066aef21694395a4b69df938501d9631 |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ADGRV1 DNAH14 FREM2 PKHD1 ALCAM LNX2 RANBP17 LLGL2 ROS1 ACOXL | 7.97e-08 | 191 | 236 | 10 | ca5669bd6f4a17471acae3eb229f845cc2e08efa |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | ADGRV1 DNAH14 CMTM8 FREM2 PKHD1 ALCAM DSCAM RANBP17 LLGL2 ACOXL | 7.97e-08 | 191 | 236 | 10 | d3733c8c4bda70c4390e5601fdda6188a64be944 |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | ADGRV1 DNAH14 CMTM8 FREM2 ALCAM LNX2 RANBP17 LLGL2 ROS1 ACOXL | 8.37e-08 | 192 | 236 | 10 | 499e8893afea5e6d3371e0bd018f7e86a524d669 |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ADGRV1 DNAH14 CMTM8 FREM2 PKHD1 ALCAM RANBP17 LLGL2 ROS1 ACOXL | 8.79e-08 | 193 | 236 | 10 | a0ca3231992f14abcf1a6129573bace320e89d2a |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ADGRV1 DNAH14 ALCAM DNAH5 LNX2 SYNE1 RANBP17 LLGL2 ROS1 ACOXL | 9.68e-08 | 195 | 236 | 10 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ADGRV1 DNAH14 CMTM8 FREM2 ALCAM LNX2 RANBP17 LLGL2 ROS1 ACOXL | 1.17e-07 | 199 | 236 | 10 | 725610310e5c5fd7120c0be9acb55bf152026ddd |
| ToppCell | C_02|World / shred on cell type and cluster | 2.54e-07 | 165 | 236 | 9 | a456c2c9ffe8dc91e17cac84ba87b88e016f8e6d | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-07 | 93 | 236 | 7 | dbfaa7f23d25f5c286ab7ca3ca795b734cb95153 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial-epithelial_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-07 | 93 | 236 | 7 | 0d6d1d8dd9c91ba31eb35a4b5979d087890936c1 | |
| ToppCell | facs-MAT-Fat-3m-Epithelial|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-07 | 93 | 236 | 7 | abffb1fd5a919b7c08e62e1c3c08a8dd8783a4ca | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 6.66e-07 | 185 | 236 | 9 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.96e-07 | 186 | 236 | 9 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CYP3A5 SLC22A11 SLC16A9 TTYH3 XPNPEP2 SLC7A7 SLC5A2 SLC7A9 SLC22A2 | 7.61e-07 | 188 | 236 | 9 | f3edcefeef2ce19086032d98b243c02a6d542b38 |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.61e-07 | 188 | 236 | 9 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | CYP3A5 SLC22A11 SLC16A9 TTYH3 XPNPEP2 SLC7A7 SLC5A2 SLC7A9 SLC22A2 | 7.61e-07 | 188 | 236 | 9 | 0792432cd4c564dea1102241ea9884f7ced7658c |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.69e-07 | 191 | 236 | 9 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.07e-07 | 192 | 236 | 9 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 9.07e-07 | 192 | 236 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.07e-07 | 192 | 236 | 9 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.89e-07 | 194 | 236 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-06 | 195 | 236 | 9 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | CTSC KCNMA1 TSPAN14 CALHM6 TTYH3 SLC7A7 SLC11A1 ASAH1 NEURL1 | 1.03e-06 | 195 | 236 | 9 | 72928a1d987a3a5361c666f3972292aefec5f548 |
| ToppCell | severe_COVID-19-Non-classical_Monocyte|severe_COVID-19 / disease group, cell group and cell class (v2) | CTSC KCNMA1 TSPAN14 CYSLTR2 CALHM6 TTYH3 SLC7A7 CALHM2 NEURL1 | 1.08e-06 | 196 | 236 | 9 | 34c1c74cad5e23196e86cfd6f19c836fe57b2264 |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-06 | 145 | 236 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | C_01|World / shred on cell type and cluster | 1.17e-06 | 198 | 236 | 9 | 71d38084d09a96331877384ce6346f0de4bdcef9 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-06 | 198 | 236 | 9 | 3b4611c9ee4d42e042a29ddb4580a95938d87d65 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-06 | 199 | 236 | 9 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-06 | 199 | 236 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-06 | 199 | 236 | 9 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial-Astrocyte|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 236 | 9 | b9bd6c4381c92bfc1bfff9aa778a62a41d08f1ef | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DPY19L3 SLC12A8 ADGRV1 CMTM8 KCNMA1 ALCAM RANBP17 LLGL2 TANC1 | 1.27e-06 | 200 | 236 | 9 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-06 | 162 | 236 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-06 | 171 | 236 | 8 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 4.27e-06 | 174 | 236 | 8 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.84e-06 | 177 | 236 | 8 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 178 | 236 | 8 | 4f1cc954d4d9b5b2b75a4cf995ba81e2ada27084 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-06 | 178 | 236 | 8 | 24e8c62060455159235985f456af0c5023a7f3f5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.26e-06 | 179 | 236 | 8 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 6.18e-06 | 183 | 236 | 8 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.18e-06 | 183 | 236 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 184 | 236 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 184 | 236 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-06 | 184 | 236 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.97e-06 | 186 | 236 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.97e-06 | 186 | 236 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.24e-06 | 187 | 236 | 8 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.53e-06 | 188 | 236 | 8 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 7.53e-06 | 188 | 236 | 8 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.14e-06 | 190 | 236 | 8 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|B_cell_maturation / Lineage and Cell class | 8.46e-06 | 191 | 236 | 8 | 4ee160a863d4fb9c4c9449633b9f337db8871992 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.78e-06 | 192 | 236 | 8 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.12e-06 | 193 | 236 | 8 | 7839040e703877ef321494ad8926a8604729ceda | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-06 | 194 | 236 | 8 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.47e-06 | 194 | 236 | 8 | 70185c0b8e0f4e896645b17a243482ba3cdf4a5d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-06 | 194 | 236 | 8 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.47e-06 | 194 | 236 | 8 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.83e-06 | 195 | 236 | 8 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | distal-2-Hematologic-Nonclassical_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.83e-06 | 195 | 236 | 8 | 34bed73e4dae34b0f1076b7ff9dc7ea2096c1796 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^medium_distal_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.83e-06 | 195 | 236 | 8 | f08e41706680881ebd0afcd08a02f8ac0089f04e | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 9.83e-06 | 195 | 236 | 8 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-goblet-BEST2+_Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-05 | 197 | 236 | 8 | d624f3a105b19f19a0dd253ce8de3ed13adc1f01 | |
| ToppCell | control-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.06e-05 | 197 | 236 | 8 | df2fe36cb96e2565a9d21c24cb4e451e8befd4be | |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.06e-05 | 197 | 236 | 8 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-05 | 198 | 236 | 8 | ab70bf89690410221ec7aa3149bb50ac34433f99 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 198 | 236 | 8 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 1.10e-05 | 198 | 236 | 8 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | COVID-19_Convalescent-Non-classical_Monocyte|COVID-19_Convalescent / Disease condition and Cell class | 1.14e-05 | 199 | 236 | 8 | c9250c80dd5bc3d27c6065b99119ff7dcf392e84 | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 199 | 236 | 8 | 174f6013af6eafa577f84205a62927f2b367fda3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.14e-05 | 199 | 236 | 8 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | COVID-19_Convalescent-Non-classical_Monocyte-|COVID-19_Convalescent / Disease condition and Cell class | 1.14e-05 | 199 | 236 | 8 | 996a207b8b91e10dd018dc07aaf5ecd473bfeaad | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Alveolar_macrophages|Lung / Manually curated celltypes from each tissue | 1.14e-05 | 199 | 236 | 8 | eec1b086e5e8b9b0e1770dd269ca903f713d99a8 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.14e-05 | 199 | 236 | 8 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 1.14e-05 | 199 | 236 | 8 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 236 | 8 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 236 | 8 | 2d2835f97e0ff4f99d384f18e10876575f6bdefd | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 236 | 8 | eac46978e2b3d38cf42b44f7b0350d0489d036b3 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.18e-05 | 200 | 236 | 8 | 77a68e8fd97a3f3467d25032067fd7ad52ab8522 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 200 | 236 | 8 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 236 | 8 | 77631c471cc5d453a749784f838cfa6408caf09b | |
| ToppCell | kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 145 | 236 | 7 | 47a3bb973a508d3097213a2d86ad1ce697af9bae | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 162 | 236 | 7 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-05 | 166 | 236 | 7 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.09e-05 | 113 | 236 | 6 | 0651fb7a7e1ea84b8365059e5ed85bf6c082da1a | |
| ToppCell | Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-Kcnj8-MURAL_Mural.Acta2Rgs5.Kcnj8-Abcc9_(Mural.Acta2Rgs5.Kcnj8-Abcc9)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.09e-05 | 113 | 236 | 6 | 0e153efddd061d7510dfc3859cc8b1a7984fa70e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-05 | 168 | 236 | 7 | fa0d251693935116adf633d02b7ec4a295100865 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-05 | 168 | 236 | 7 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.23e-05 | 168 | 236 | 7 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-2_VIP_RPL41P3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.48e-05 | 170 | 236 | 7 | 31e3f57673c99f4d8ef30faa9c40e5f7f5bf6460 | |
| ToppCell | ileum|World / shred on tissue and cell subclass | 3.48e-05 | 170 | 236 | 7 | 9f1211bd4287620e19a59f21e6ecdca3e42e0260 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.75e-05 | 172 | 236 | 7 | 9a1743abcd5fbd38253ea84d88ad716cfb71de36 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-05 | 174 | 236 | 7 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 4.34e-05 | 176 | 236 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.50e-05 | 177 | 236 | 7 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 4.50e-05 | 177 | 236 | 7 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 4.50e-05 | 177 | 236 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | B_cell_maturation-CD34+_pre-plamsa|World / Lineage and Cell class | 4.50e-05 | 177 | 236 | 7 | 3ff06100deee9bee852a52078666999a9f7beaf1 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 178 | 236 | 7 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.66e-05 | 178 | 236 | 7 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.83e-05 | 179 | 236 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| Drug | 2-benzoylpyridine | 3.41e-07 | 7 | 229 | 4 | CID000007038 | |
| Drug | Nortriptyline | 1.76e-06 | 21 | 229 | 5 | ctd:D009661 | |
| Drug | NSC294574 | 3.99e-06 | 4 | 229 | 3 | CID000325604 | |
| Drug | niflumic acid | 5.01e-06 | 125 | 229 | 9 | CID000004488 | |
| Drug | Verapamil | 1.65e-05 | 16 | 229 | 4 | DB00661 | |
| Drug | trans-1,2-diphenylethylene | 2.47e-05 | 117 | 229 | 8 | CID000011502 | |
| Drug | Racemic mixture | 2.54e-05 | 58 | 229 | 6 | CID000365464 | |
| Drug | Fluvoxamine | 2.73e-05 | 18 | 229 | 4 | ctd:D016666 | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; PC3; HT_HG-U133A | CYP3A5 SPTA1 HEMK1 CACNA1G SOCS3 SLC4A1 SLC5A3 LLGL1 SLC11A1 NEURL1 | 2.98e-05 | 195 | 229 | 10 | 4576_UP |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; MCF7; HT_HG-U133A | ADRA1B ACAN NYNRIN GLP1R NNAT SLC11A2 FSCN3 SLC4A1 LLGL1 SLC16A5 | 3.12e-05 | 196 | 229 | 10 | 3907_UP |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A | CYP3A5 MGAT3 CYSLTR2 FFAR2 NTRK3 SOCS3 SLC5A3 SLC7A9 SLC11A1 SLC16A5 | 3.40e-05 | 198 | 229 | 10 | 6088_UP |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; PC3; HT_HG-U133A | CYBRD1 CYP3A5 GLP1R CACNA1G NNAT TDRKH NTRK3 SOCS3 SLC11A1 SLC16A5 | 3.40e-05 | 198 | 229 | 10 | 6751_UP |
| Drug | Hydroxyzine | 3.41e-05 | 7 | 229 | 3 | ctd:D006919 | |
| Drug | 3-MeO | 3.41e-05 | 7 | 229 | 3 | CID009574960 | |
| Drug | Dextropropoxyphene | 3.41e-05 | 7 | 229 | 3 | ctd:D011431 | |
| Drug | azosemide | 3.43e-05 | 19 | 229 | 4 | CID000002273 | |
| Drug | PF-00539758-00 [351321-34-1]; Down 200; 10uM; PC3; HT_HG-U133A | CYP3A5 CLCN7 ACAN HEMK1 ALG12 DNAH3 DSCAM SLC11A1 SLC16A5 MEGF8 | 3.55e-05 | 199 | 229 | 10 | 6379_DN |
| Drug | Neostigmine bromide [114-80-7]; Up 200; 13.2uM; PC3; HT_HG-U133A | PAPOLB ALOX12 AGAP2 TDRKH NTRK3 SOCS3 ABCC9 SLC11A1 EGFL7 ACOXL | 3.55e-05 | 199 | 229 | 10 | 6735_UP |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 3.71e-19 | 46 | 229 | 14 | DOID:5426 (implicated_via_orthology) |
| Disease | congenital heart disease (implicated_via_orthology) | USP17L21 USP17L20 USP17L19 USP17L18 USP17L17 USP17L13 USP17L12 USP17L11 USP17L24 USP17L5 USP17L10 USP17L6P USP17L22 USP17L15 | 2.04e-16 | 69 | 229 | 14 | DOID:1682 (implicated_via_orthology) |
| Disease | osteopetrosis (implicated_via_orthology) | 1.58e-05 | 7 | 229 | 3 | DOID:13533 (implicated_via_orthology) | |
| Disease | Drug habituation | 3.33e-05 | 115 | 229 | 7 | C0013170 | |
| Disease | Drug abuse | 3.33e-05 | 115 | 229 | 7 | C0013146 | |
| Disease | Prescription Drug Abuse | 3.33e-05 | 115 | 229 | 7 | C4316881 | |
| Disease | Substance-Related Disorders | 3.33e-05 | 115 | 229 | 7 | C0236969 | |
| Disease | Drug Use Disorders | 3.33e-05 | 115 | 229 | 7 | C0013222 | |
| Disease | Drug Dependence | 3.33e-05 | 115 | 229 | 7 | C1510472 | |
| Disease | Substance Dependence | 3.33e-05 | 115 | 229 | 7 | C0038580 | |
| Disease | Substance Use Disorders | 3.33e-05 | 115 | 229 | 7 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 3.33e-05 | 115 | 229 | 7 | C0029231 | |
| Disease | Substance abuse problem | 3.52e-05 | 116 | 229 | 7 | C0740858 | |
| Disease | dermoid cyst of ovary (implicated_via_orthology) | 6.00e-05 | 2 | 229 | 2 | DOID:5117 (implicated_via_orthology) | |
| Disease | Chronic depression | 6.00e-05 | 2 | 229 | 2 | C0581391 | |
| Disease | spermatogenesis-associated protein 20 measurement | 6.00e-05 | 2 | 229 | 2 | EFO_0802083 | |
| Disease | uric acid measurement | SLC22A11 ADGRV1 CNTROB SLC22A10 KLB SFMBT1 DNAH3 SLC16A9 DSCAM DYNC2H1 XPNPEP2 SLC7A9 ABCA6 TANC1 ATP2A2 | 9.35e-05 | 610 | 229 | 15 | EFO_0004761 |
| Disease | obesity (biomarker_via_orthology) | 1.57e-04 | 147 | 229 | 7 | DOID:9970 (biomarker_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.71e-04 | 36 | 229 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | Dent disease (implicated_via_orthology) | 1.79e-04 | 3 | 229 | 2 | DOID:0050699 (implicated_via_orthology) | |
| Disease | secretory phospholipase A2 receptor measurement | 1.79e-04 | 3 | 229 | 2 | EFO_0802043 | |
| Disease | Juvenile amyotrophic lateral sclerosis | 1.79e-04 | 3 | 229 | 2 | cv:C3468114 | |
| Disease | coronary restenosis (biomarker_via_orthology) | 1.79e-04 | 3 | 229 | 2 | DOID:4247 (biomarker_via_orthology) | |
| Disease | Malignant Glioma | 2.16e-04 | 70 | 229 | 5 | C0555198 | |
| Disease | mixed gliomas | 2.16e-04 | 70 | 229 | 5 | C0259783 | |
| Disease | Ciliopathies | 2.24e-04 | 110 | 229 | 6 | C4277690 | |
| Disease | glucose homeostasis measurement, acute insulin response measurement | 3.45e-04 | 18 | 229 | 3 | EFO_0006831, EFO_0006896 | |
| Disease | Hereditary elliptocytosis | 3.56e-04 | 4 | 229 | 2 | cv:C0013902 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 3.56e-04 | 4 | 229 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Juvenile amyotrophic lateral sclerosis | 3.56e-04 | 4 | 229 | 2 | C3468114 | |
| Disease | Hypokalemic periodic paralysis | 3.56e-04 | 4 | 229 | 2 | C0238358 | |
| Disease | Nephritis, Tubulointerstitial | 5.53e-04 | 21 | 229 | 3 | C0041349 | |
| Disease | hereditary spherocytosis (is_implicated_in) | 5.91e-04 | 5 | 229 | 2 | DOID:12971 (is_implicated_in) | |
| Disease | programmed cell death protein 5 measurement | 5.91e-04 | 5 | 229 | 2 | EFO_0801927 | |
| Disease | Hereditary spherocytosis | 5.91e-04 | 5 | 229 | 2 | cv:C0037889 | |
| Disease | Fahr's syndrome (disorder) | 5.91e-04 | 5 | 229 | 2 | C0393590 | |
| Disease | Anemia, hereditary spherocytic hemolytic | 5.91e-04 | 5 | 229 | 2 | C0221409 | |
| Disease | neuroblastoma (implicated_via_orthology) | 5.91e-04 | 5 | 229 | 2 | DOID:769 (implicated_via_orthology) | |
| Disease | estrone measurement | 5.91e-04 | 5 | 229 | 2 | EFO_0007970 | |
| Disease | X-17357 measurement | 5.91e-04 | 5 | 229 | 2 | EFO_0800777 | |
| Disease | X-12798 measurement | 5.91e-04 | 5 | 229 | 2 | EFO_0021335 | |
| Disease | Glioma | 5.94e-04 | 87 | 229 | 5 | C0017638 | |
| Disease | Nephritis, Interstitial | 8.28e-04 | 24 | 229 | 3 | C0027707 | |
| Disease | VACTERL association (implicated_via_orthology) | 8.81e-04 | 6 | 229 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Elliptocytosis, Hereditary | 8.81e-04 | 6 | 229 | 2 | C0013902 | |
| Disease | basal ganglia calcification (is_implicated_in) | 8.81e-04 | 6 | 229 | 2 | DOID:0060230 (is_implicated_in) | |
| Disease | Obesity | 1.15e-03 | 205 | 229 | 7 | C0028754 | |
| Disease | hepatocyte growth factor receptor measurement | 1.23e-03 | 7 | 229 | 2 | EFO_0008153 | |
| Disease | homocitrulline measurement | 1.23e-03 | 7 | 229 | 2 | EFO_0021018 | |
| Disease | Disorder of eye | 1.40e-03 | 212 | 229 | 7 | C0015397 | |
| Disease | Neurotoxicity Syndromes | 1.45e-03 | 29 | 229 | 3 | C0235032 | |
| Disease | Encephalopathy, Toxic | 1.45e-03 | 29 | 229 | 3 | C0149504 | |
| Disease | Toxic Encephalitis | 1.45e-03 | 29 | 229 | 3 | C0154659 | |
| Disease | metabolite measurement | CYP3A5 CES1 SPTA1 UNC93A ALCAM SLC16A9 MPV17L2 DSCAM SLC7A9 ASAH1 SLC22A2 MTNR1B | 1.53e-03 | 560 | 229 | 12 | EFO_0004725 |
| Disease | Hereditary spherocytosis | 1.63e-03 | 8 | 229 | 2 | C0037889 | |
| Disease | gallbladder neoplasm | 2.08e-03 | 9 | 229 | 2 | EFO_0004606 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 2.08e-03 | 9 | 229 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Polydactyly | 2.23e-03 | 117 | 229 | 5 | C0152427 | |
| Disease | systolic blood pressure, body mass index | 2.31e-03 | 34 | 229 | 3 | EFO_0004340, EFO_0006335 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 2.66e-03 | 74 | 229 | 4 | EFO_0007869, EFO_0007878 | |
| Disease | total blood protein measurement | CYP19A1 CEMIP2 NYNRIN PKHD1 DNAH3 SLC4A1 SLC6A4 ABCA6 SLC22A2 ACOXL | 2.83e-03 | 449 | 229 | 10 | EFO_0004536 |
| Disease | pulse pressure measurement | CYBRD1 SPG7 MYO1C ZCCHC2 QSOX1 ADRA1B ULK4 TSPAN14 KLB FOXO3 DSCAM DYNC2H1 PCDHA13 ABCC9 PCDHA2 MEGF8 ASAH1 SLC22A2 MTNR1B EIF2AK4 XPR1 | 2.91e-03 | 1392 | 229 | 21 | EFO_0005763 |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.95e-03 | 37 | 229 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | lean body mass | 2.98e-03 | 379 | 229 | 9 | EFO_0004995 | |
| Disease | endometrial endometrioid carcinoma | 3.15e-03 | 11 | 229 | 2 | EFO_1001514 | |
| Disease | level of Sphingomyelin (d34:0) in blood serum | 3.15e-03 | 11 | 229 | 2 | OBA_2045176 | |
| Disease | smoking status measurement, forced expiratory volume | 3.15e-03 | 11 | 229 | 2 | EFO_0004314, EFO_0006527 | |
| Disease | kidney cancer (implicated_via_orthology) | 3.15e-03 | 11 | 229 | 2 | DOID:263 (implicated_via_orthology) | |
| Disease | invasive ductal carcinoma (is_marker_for) | 3.69e-03 | 40 | 229 | 3 | DOID:3008 (is_marker_for) | |
| Disease | Pulmonary Hypertension | 3.69e-03 | 40 | 229 | 3 | C0020542 | |
| Disease | Night blindness, congenital stationary, type 1 | 3.76e-03 | 12 | 229 | 2 | C3501847 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 3.76e-03 | 12 | 229 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 3.76e-03 | 12 | 229 | 2 | C1864877 | |
| Disease | methionine sulfone measurement | 3.76e-03 | 12 | 229 | 2 | EFO_0800072 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 3.76e-03 | 12 | 229 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 3.76e-03 | 12 | 229 | 2 | C3711543 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 3.76e-03 | 12 | 229 | 2 | C1848172 | |
| Disease | Autism Spectrum Disorders | 4.38e-03 | 85 | 229 | 4 | C1510586 | |
| Disease | Amino Acid Metabolism, Inherited Disorders | 4.42e-03 | 13 | 229 | 2 | C0750905 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 4.42e-03 | 13 | 229 | 2 | C4041558 | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 4.42e-03 | 13 | 229 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | Amino Acid Metabolism, Inborn Errors | 4.42e-03 | 13 | 229 | 2 | C0002514 | |
| Disease | urate measurement | SLC22A11 HLA-F ADGRV1 ALDH16A1 PKHD1 HEATR5B TECPR1 KLB SFMBT1 DNAH3 SLC16A9 SLC4A1 SLC7A9 USP17L6P EEF1AKMT2 | 4.48e-03 | 895 | 229 | 15 | EFO_0004531 |
| Disease | Malignant neoplasm of breast | IDO1 CYP19A1 ABCB1 DDX10 SLC2A10 AGAP2 MAP2K4 DYNC2H1 NOA1 SYNE1 ABCB6 MSI1 SLC7A7 APOBEC3B LLGL2 LLGL1 TLL1 | 4.51e-03 | 1074 | 229 | 17 | C0006142 |
| Disease | visceral adipose tissue measurement | TRIP12 GPR158 PKHD1 ULK4 ALCAM FOXO3 SLC6A4 RANBP17 LLGL1 HSD17B12 | 4.58e-03 | 481 | 229 | 10 | EFO_0004765 |
| Disease | Kidney Diseases | 4.95e-03 | 88 | 229 | 4 | C0022658 | |
| Disease | cancer (implicated_via_orthology) | 5.12e-03 | 268 | 229 | 7 | DOID:162 (implicated_via_orthology) | |
| Disease | Metabolic Bone Disorder | 5.13e-03 | 14 | 229 | 2 | C0005944 | |
| Disease | Sclerocystic Ovaries | 5.42e-03 | 144 | 229 | 5 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 5.42e-03 | 144 | 229 | 5 | C0032460 | |
| Disease | total lipids in small LDL | 5.82e-03 | 47 | 229 | 3 | EFO_0022168 | |
| Disease | end stage renal disease (biomarker_via_orthology) | 5.82e-03 | 47 | 229 | 3 | DOID:783 (biomarker_via_orthology) | |
| Disease | Osteopenia | 5.89e-03 | 15 | 229 | 2 | C0029453 | |
| Disease | response to olanzapine | 5.89e-03 | 15 | 229 | 2 | GO_0097333 | |
| Disease | platelet component distribution width | SPTA1 NYNRIN ALG12 FOXO3 LNX2 SLC16A9 SYNE1 CLDN3 TTYH3 EEF1AKMT2 EIF2AK4 EGFL7 ACOXL | 6.39e-03 | 755 | 229 | 13 | EFO_0007984 |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.42e-03 | 150 | 229 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | cholestasis (biomarker_via_orthology) | 6.54e-03 | 49 | 229 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | diastolic blood pressure, body mass index | 6.70e-03 | 16 | 229 | 2 | EFO_0004340, EFO_0006336 | |
| Disease | Intrahepatic cholestasis of pregnancy | 6.70e-03 | 16 | 229 | 2 | EFO_0009048 | |
| Disease | lysosomal storage disease (implicated_via_orthology) | 6.70e-03 | 16 | 229 | 2 | DOID:3211 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SILYLQFWIRSGGGV | 1396 | Q96QE3 | |
| VTIQYRLGIWGFFST | 166 | P23141 | |
| GFSQLLLLWRGSIYK | 16 | Q8NFU1 | |
| LRAQLWGYTQFLALG | 196 | P51689 | |
| WGYTQFLALGILTLA | 201 | P51689 | |
| WLLVLAVGGTEHAYR | 11 | Q9UHF1 | |
| GTYLATFHQRGIALW | 346 | P55884 | |
| YWRFLALLGSALLVG | 6 | Q53TN4 | |
| LSFYVLGSWLGGTQR | 761 | Q2NKJ3 | |
| ETATGGFVLLYEWVL | 301 | Q9P2K8 | |
| SNLLWDTGVFRGQVY | 46 | Q9UH17 | |
| WSERLGQALELGYGL | 431 | Q8IZ83 | |
| TNGLEYIVGRVWIGF | 481 | P02730 | |
| GVWSIAAGRDYSLFL | 611 | Q96Q42 | |
| LLWLGVFLSISGYCQ | 16 | Q9UKJ8 | |
| LLGNVLSYRQGLWKF | 46 | P20815 | |
| IIGTITNGLYLWVLR | 41 | Q49SQ1 | |
| SWGLIYAGFIFIISI | 266 | Q8N139 | |
| LRLDTYFIWSFIGPA | 1001 | Q9HAR2 | |
| FRGIYGISNLTWAVE | 5276 | Q8WXG9 | |
| FSLWVLRYVVSGGLF | 186 | Q9NP58 | |
| LRYVVSGGLFVLGLW | 191 | Q9NP58 | |
| FSAALEVLGYWVLGR | 101 | P35368 | |
| ITQLLLWYGADVAAR | 1106 | Q99490 | |
| YFLALGGWVGIIAST | 11 | Q8N6F1 | |
| SYGAALLRAWLVLGV | 586 | Q96C12 | |
| SFGILLWEIYSFGRV | 371 | P41240 | |
| TCWRYLTSGGFFLLI | 981 | O60706 | |
| RFSINGGYLGILEWI | 226 | Q13510 | |
| TLVASYFLEWRSVLG | 206 | Q8TAP6 | |
| YFLEWRSVLGSENGV | 211 | Q8TAP6 | |
| LSGLLAAFWYVTNRI | 186 | Q6ZPD9 | |
| LEVFYNGTWGSVGRR | 1156 | Q9NR16 | |
| YRTGISTLLFLVGAW | 81 | Q6ZW61 | |
| IIYWLFGGAIRNLGS | 56 | Q9NUZ1 | |
| LGLTVAVDSYFWRQL | 221 | Q9BV10 | |
| LFGSWELIYGASQEL | 66 | Q8N4T4 | |
| WSLGITLYELATGRF | 291 | P45985 | |
| DVLARWSDGLFYLGT | 51 | Q9Y483 | |
| TIQEGRLAWLVYLVG | 486 | Q9H2T7 | |
| ILVYDIANRWSFDGI | 91 | Q12829 | |
| GAQGILLVYDITNRW | 86 | Q96S21 | |
| LLVYDITNRWSFDGI | 91 | Q96S21 | |
| QWLQVLGGGFSYLDI | 696 | O00391 | |
| ALGFYPAEITLTWQR | 226 | P30511 | |
| WLSYELQLGTGSARI | 606 | Q9Y5H9 | |
| ILIGYSRGLLVIWNQ | 211 | Q15334 | |
| ANLGTGIIISFIYGW | 841 | P08183 | |
| YQFVAGWTLLGSDLI | 201 | Q8NGH8 | |
| TVGLREVWFFGLQYV | 36 | P35241 | |
| LLEIGGSQNLRFYWK | 126 | Q8N8L6 | |
| VVTIQYRLGIWGFFS | 166 | Q9UKY3 | |
| IAARWGYQGVIETLL | 571 | Q96NW4 | |
| NIYSNILGFLGGVSW | 236 | Q9NRJ5 | |
| FFNYTVRTLGLGEEW | 61 | O60568 | |
| SAYIRNGWNLLDFII | 156 | O60840 | |
| LAVGVLYIEWLDAFG | 31 | Q7RTY1 | |
| FFSVLRIYLSGWKGN | 226 | P14902 | |
| GLFQYGWINSLLFVV | 31 | Q8NG84 | |
| ERWTDGSSLGINFLY | 196 | P09237 | |
| WALGVITYALLSGFL | 246 | Q96QS6 | |
| STWLLAGISIERYLG | 96 | O15552 | |
| FRVTYINGLTLGWDT | 166 | Q567V2 | |
| LSPYLAGWRALVEFL | 101 | A6NH11 | |
| VTFFGGLFIILLWRT | 96 | Q12791 | |
| IGYSRGLVVIWDLQG | 206 | Q6P1M3 | |
| GLVVIWDLQGSRVLY | 211 | Q6P1M3 | |
| AASAELLIIGWYIFR | 6 | Q16517 | |
| LWFISSENYLIIGGR | 531 | O60524 | |
| DLNYIRGLIRTGGWF | 451 | Q09327 | |
| RLGLTSYRDFLGTNW | 81 | Q9BRQ3 | |
| FLLGSVWLDYVGSVL | 16 | Q16288 | |
| LRPGWLITLSATFYG | 241 | Q6PRD1 | |
| FRLYVSIGWGVPLLF | 266 | P43220 | |
| WARLLGFATVYGTVT | 486 | Q5T848 | |
| GTIGLSWTFLLYGLT | 471 | O95528 | |
| SWTFLLYGLTAVLGL | 476 | O95528 | |
| RLLLWTQQATEGYAG | 156 | Q03001 | |
| QYILGEWDFQGLSLR | 111 | Q9Y5R4 | |
| RYWALGLVVGSHLLT | 186 | Q96BI3 | |
| GRTGTSWAFILLFYL | 31 | P14415 | |
| RLTFVYDTAILWNDG | 2701 | Q5SZK8 | |
| LILVAIFYDGWALGE | 96 | P49286 | |
| IVLRRSYLGSWGFSI | 601 | Q8N448 | |
| RYESQLFGWLLIGVV | 181 | Q9HA72 | |
| GVLGAVFNALNYWLT | 386 | P51798 | |
| FYRQLTSDGQLRWIG | 91 | Q7L5Y1 | |
| LGILWFEAREISLYS | 91 | A6NGY5 | |
| WLSLQYLGLDGFVER | 341 | Q6P474 | |
| LVGGWSFSLYLIQLV | 221 | O14524 | |
| FRLDSTSGGYWEQVI | 366 | Q7Z7M0 | |
| GIAKIFWIGLNQLYS | 271 | O60449 | |
| GLVRAWTVTAGYLLD | 551 | O60337 | |
| LYIWAIGLLAAGQSS | 361 | P49279 | |
| ALYIWAVGILAAGQS | 371 | P49281 | |
| TIGLREVWFFGLQYQ | 36 | P26038 | |
| YRFSDGWDIITLGQV | 241 | Q8TCJ0 | |
| IRVATGAWLFSGSYN | 6 | P18054 | |
| GNGAVLWLLSSNVYR | 41 | Q86SM8 | |
| TGNYELAVALSRWVF | 286 | P39656 | |
| GLSWQTTQEGLREYF | 26 | O43347 | |
| WLFASLSYDGRLVIN | 361 | Q53HC9 | |
| LGARLATTGQLYLAW | 276 | P16112 | |
| NLGTGIIISFIYGWQ | 841 | P21439 | |
| WLSYELQLAAVGARI | 606 | Q9Y5I0 | |
| GLWRTFDSVVFYLTL | 6 | Q86SM5 | |
| YQFVIGWTLLGSDLI | 201 | P0C7T3 | |
| IYSNILGFLGGVSWA | 236 | P51003 | |
| WLFLARYVEGVGSQQ | 96 | Q9H3Q3 | |
| QWVLGLFRYDLEGGS | 2501 | Q8NCM8 | |
| AWGNLSYADLITRAI | 241 | A0A2Z4LIS9 | |
| PLISGWLFFRYLAIG | 826 | P16615 | |
| GVSFFVLSLILGYSW | 301 | P50993 | |
| LGYSWLEAVIFLIGI | 311 | P50993 | |
| YVVFVTTLGGQWLER | 311 | Q9P2D3 | |
| YLLSSGRFLGEKVWQ | 51 | Q96PB1 | |
| GYAWIAIFQVITLEG | 341 | O43497 | |
| LTGLFLLVWNYEGTS | 31 | P11511 | |
| EVWYFLLTGGIALDN | 3391 | Q8TD57 | |
| AYLRSGWNVLDFTIV | 116 | Q13698 | |
| LTWVAVALLGGAFYE | 111 | Q5R3K3 | |
| LQTFREYGDTGEIWF | 46 | Q5JPI9 | |
| LSVGAISLAFYNGLW | 216 | P82251 | |
| AGWLVIAVGLVRAYL | 51 | Q6Y1H2 | |
| LRQWGLTGIHLRSYQ | 36 | Q86WJ1 | |
| ATKGFNWYGTERLIR | 846 | Q86WJ1 | |
| ILSGFIIRGYLGKWT | 246 | P51795 | |
| LRVGLISWAGTYLTF | 16 | Q9NQT6 | |
| IQGLFYGSLTFGIWT | 6 | Q7Z4T8 | |
| YGSLTFGIWTALLFI | 11 | Q7Z4T8 | |
| TYLDLLGTWVFQVGS | 31 | P53634 | |
| ISYSLFTALRVWGVG | 26 | Q53GQ0 | |
| SELIQGLGYRQAWAL | 336 | Q9UHN6 | |
| VYIFGLFIEGARWNR | 3396 | Q0VDD8 | |
| QRRWVYLEGIFTGSA | 1541 | Q14204 | |
| EIRVFGYTAWSLLDG | 451 | Q86Z14 | |
| QVFISLLLWISGAYG | 6 | P06312 | |
| LYRLQWTSTDGLGVL | 131 | Q13206 | |
| ISGLLFIYQEVSRLW | 16 | A6NNS2 | |
| STWEQGLRILGLEYS | 1291 | Q9BYK8 | |
| WGALRGLETFSQLVY | 166 | P07686 | |
| GILIRSARGIFFWIF | 586 | P54803 | |
| LAGWIIYALGRVEVT | 611 | P54803 | |
| SGILVGSFIWGLLSY | 151 | Q9NSA0 | |
| LGSLAAVGISWFLYI | 266 | A0AV02 | |
| YLFRITAQTRKGWGE | 1371 | Q58EX2 | |
| WGVASIGTFFIILYN | 556 | Q9NTJ5 | |
| AGWLIGYILITEFVG | 216 | O15244 | |
| LISATVFRPGLGWYT | 16 | Q13740 | |
| GYGVEELISALQRSW | 321 | Q8NC60 | |
| EVSQLLRLYQARGWG | 806 | Q8N137 | |
| LWIYLEAVFVGGDIA | 1631 | Q8TE73 | |
| GFVLLGLSQVWELRF | 11 | Q8NGN0 | |
| LNRIYQFVAGWTLLG | 201 | Q8NGH5 | |
| WVGPFYIGDRLSLSL | 1846 | Q9P2P1 | |
| YIGDRLSLSLYRIWG | 1851 | Q9P2P1 | |
| ARWVRLNVGGTYFVT | 71 | Q14681 | |
| RIGWRYSLLFVGLLQ | 176 | O15403 | |
| QRATVSWLYGGLIAV | 141 | Q8NHC5 | |
| TGWSLAFLAFERYIV | 121 | P03999 | |
| ALNGILQGFRVIYWA | 1116 | O60469 | |
| AWGNLSYADLITRAI | 156 | O43524 | |
| FYLWRVGILLSSAQI | 366 | A8MW99 | |
| WVFTYVGALFNGLTL | 1126 | Q9NQC3 | |
| FTVRVALRYILAGWG | 146 | O14804 | |
| RYISFLWQVADLGSS | 1016 | Q93008 | |
| YDRVLFWGRILGLVA | 41 | Q9H1X1 | |
| GQSQGLIWDFGYLTL | 391 | P52630 | |
| LIWDFGYLTLVEQRS | 396 | P52630 | |
| LVWLVASGIVFYGEL | 11 | O43897 | |
| YGLGLERFLTWILNR | 516 | O43776 | |
| LGTIGAWLYRAEVAL | 411 | Q8NF91 | |
| IILGGLAYVFRDWQT | 246 | Q63ZE4 | |
| GYFLIATVWTLGFAI | 156 | Q15761 | |
| RFWHSGPGQVLTYLL | 331 | Q7Z6Z6 | |
| LAGWHRIAIIYLLSG | 686 | Q96CC6 | |
| NLGAILTYAVVGTLW | 131 | Q14940 | |
| GALFIQESLGWNLYV | 146 | P53794 | |
| LQALWIGYSTEGLSA | 886 | Q9C0D5 | |
| QYFWLLVLSRGLVGI | 191 | Q8IVW8 | |
| WTFLSRILTGLNYEA | 276 | Q15738 | |
| YGWIITGRLETFDFD | 156 | P08F94 | |
| IDQTRGWFYTLLVLA | 561 | P41252 | |
| GWFYTLLVLATALFG | 566 | P41252 | |
| LWQLLGGTFYFNTSR | 91 | Q9UQ90 | |
| GILLNGVSGWIFFYV | 36 | Q15391 | |
| QTGLARTGRWLAVDY | 266 | P04181 | |
| LTVVLNRLGYAHWIG | 1161 | Q13018 | |
| VIRTDLGYTVFQWLG | 216 | O43868 | |
| AGLYVGWAAAALQLL | 161 | O15551 | |
| LGLLVWTLIAGTEYF | 51 | Q8IZV2 | |
| WGVLGNGLSIYVFLQ | 51 | Q9NS75 | |
| TILSGFIIRGYLGKW | 246 | P51790 | |
| LYGLGSWLFARVTET | 121 | A6NNL5 | |
| ERVYEWFGLVLGSAQ | 96 | Q9C0B9 | |
| GILFVLSSLGWIYIF | 211 | Q96JI7 | |
| LSSLGWIYIFDVVDG | 216 | Q96JI7 | |
| TLLATGSYDGFARIW | 301 | O60907 | |
| FLFLLGINTYGWRQA | 281 | Q9UBH6 | |
| IRWFQGAGLSREAIY | 191 | Q5JXA9 | |
| LSWAYLVLVTQAGGS | 136 | Q9HA65 | |
| DTFIGYLVGNTLWLV | 186 | Q53HI1 | |
| YQKGISLWAIVFILG | 246 | Q8N609 | |
| VIYWERLLLGSGSGQ | 141 | O75467 | |
| ALRGLEGYTWRVAQL | 586 | Q86XI8 | |
| TNGSWYRARVLGTLE | 366 | Q9Y2W6 | |
| YLLENLGWRGTFLVF | 161 | O15375 | |
| WALVDVYGLTRGVQL | 201 | O76050 | |
| GWNIYASVIALLGIT | 171 | P31639 | |
| FWEVQYGILAGALVS | 446 | Q86WA9 | |
| YFLTAGDQGTLRVWE | 261 | Q12788 | |
| WGFLEDYAFVVRGLL | 571 | Q8TB22 | |
| LWAVDLFGRVYTLST | 6 | Q7Z6L1 | |
| FFVGLSIVGQLYLRW | 391 | Q9UM01 | |
| TLIHQIFGGYWRSQI | 191 | D6R9N7 | |
| TLIHQIFGGYWRSQI | 191 | A8MUK1 | |
| NYRLWEALGFVIAFG | 386 | Q86WB7 | |
| TLIHQIFGGYWRSQI | 191 | D6R901 | |
| TLIHQIFGGYWRSQI | 191 | C9JLJ4 | |
| FYWSAVTGGEANLLL | 46 | O14543 | |
| LYFRDLGAQISWVTV | 76 | Q9NZ01 | |
| TLIHQIFGGYWRSQI | 191 | D6RCP7 | |
| YSGRLFWINGFRIIT | 891 | P08922 | |
| QWILETRAYFLDGSL | 2171 | P02549 | |
| PRYISFLWQVADLGS | 1016 | O00507 | |
| GGLFWTRKLSTYIRL | 71 | Q14997 | |
| TLIHQIFGGYWRSQI | 191 | C9JPN9 | |
| TLIHQIFGGYWRSQI | 191 | Q0WX57 | |
| YLFQLGFGELWRVQE | 496 | O60346 | |
| ITAVRGSYLWLQLEG | 406 | Q9UHJ3 | |
| ATTFLRQRGYGWLLE | 51 | Q9BSR8 | |
| SYNIIFWLAGVVFLG | 21 | Q8NG11 | |
| SIQAYSLGDVRIWIG | 311 | O43895 | |
| TLIHQIFGGYWRSQI | 191 | Q6QN14 | |
| TESVGQLWLGLLRFY | 1231 | Q5VYS8 | |
| TLIHQIFGGYWRSQI | 191 | D6RA61 | |
| SVIGYAVDLGNVWRF | 91 | P31645 | |
| ATQIFYSLSVAWGGL | 316 | Q9UN76 | |
| GIIWIYGGNRFIEDT | 496 | Q9UN76 | |
| YLRLVIFWALNEGVS | 1821 | Q14669 | |
| GELWLGLLRFYTEEF | 1186 | Q5TAX3 | |
| ETLLGYTAAIPFWRN | 176 | Q9C0H2 | |
| TLIHQIFGGYWRSQI | 191 | C9J2P7 | |
| TLIHQIFGGYWRSQI | 191 | D6RBQ6 | |
| FIDVGGYKLLNNWLT | 66 | Q96QC0 | |
| LYGAILFTLQQTRWL | 191 | Q9H6F2 | |
| AFTFSRWLLSGGVYV | 156 | Q8NFA0 | |
| RWLLSGGVYVTLTDD | 161 | Q8NFA0 | |
| TLIHQIFGGYWRSQI | 191 | D6RJB6 | |
| GEIGPILWYLFRHST | 646 | Q96C45 | |
| TLIHQIFGGYWRSQI | 191 | C9JJH3 | |
| TLIHQIFGGYWRSQI | 191 | C9JVI0 | |
| WYTSVGFGGLVQLRR | 201 | Q06643 | |
| AYQLLAWRSGRVVGS | 141 | Q6ZT21 | |
| WRSTTVLGLLDIYGF | 411 | O00159 | |
| VLAYLFAQLSLWSRG | 491 | Q6IA69 | |
| DAFVKGIYGRLFVWI | 396 | Q13402 | |
| FGGILERYWLSSRAA | 221 | Q6NSJ0 | |
| SETLAVRGFSVIGWY | 641 | Q5VVJ2 |